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Natural products are bioactive small molecules from the environment 
1.1 Natural products have been in use as medicines for millennia 
During prehistory herbalists and shamans were known to utilize natural products (NP) in order to 
alleviate medical ailments.  Often in the form of tinctures, salves and elixirs, early physicians 
made use of what crude natural samples were available at the time in the formation of the earliest 
pharmaceuticals (1).  One of the best examples of harnessing the power of the environment for 
medical benefit is that of the Salix alba plant.  First discussed by Greek physician Hippocrates in 
the fifth century BCE, the dried, crystalline powder resulting from resin dried willow bark resin 
was noted for its ability to ease aches, relax pains and reduce fevers. In 1826, German chemist 
Johann Buchner isolated the active compound, which he termed salicin.  By stripping the sugar 
and oxidizing the compound to the benzoic acid, Italian chemist Rafaelle Piria, was able to 
synthesize salicylic acid, the chemical precursor for the aspirin.  Since then pharmacognosy has 
become increasingly important to the modern pharmaceutical paradigm (2-5).  As of 2012, 
approximately 80% of all drugs available on the U.S. market were themselves NPs, NP-
derivatives or NP-inspired chemicals (6, 7).  
 
1.2 Bioactive secondary metabolites are produced by enzyme megasynthases 
The observed breadth of biological activity of these environmentally isolable small molecules is 
predicated on a complex molecular architecture.  The vast sampling of chemical space is built on 
a scaffold of subunits assembled by a unique set of coevolved modular enzymatic machinery (8-
11).  Polyketide synthases (PKS) and nonribosomal peptide synthethases (NRPS) are large 
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multidomain enzymes that catalyze the stepwise addition of simple chemicals in a prototypically 
unidirectional fashion, in order to generate small molecules with potent biological activity.   
 
PKSs and NRPSs share both a common strategy and domain architecture in the biosynthesis of 
NPs.  The three core PKS domains are found in the order, ketosynthase (KS), acyltranferase 
(AT), and acyl carrier protein (ACP).  The ACP is a noncatalytic protein that is 
posttranslationally modified at an invariant serine with a Coenzyme A (CoA) derived 
phosphopantetheine (PPant), the terminal thiol of which acts as a chemical tether responsible for 
shuttling the nascent chain between catalytic domains.  AT domains selectively transfer simple 
acyl-Coenzyme A derivatives, such as malonic acid, onto the PPant arm of the downstream ACP 
domain.  KS domains are bifunctional catalyzing the transfer of the nascent intermediate from 
the upstream or donor module to a cysteine in the KS active site of the acceptor module.  
Subsequent decarboxylation of the elongation unit appended to the downstream ACP and 
Claisen-like condensation with the growing chain, constituting one round of canonical PKS 
elongation (Figure 1) (8). 











































ACP ACP ACP ACPKS AT ACP KS AT ACP KS AT ACP KS AT ACP
A.
B.
Figure 1.  Polyketide synthase (PKS) enzyme strategy A.  Acyltransferase (AT) catalyzed activation of short chain acyl-CoAs 
and transfer to acyl carrier protein (ACP) B.  Intermodule interaction and ketosynthase (KS) catalyzed bond formation.   
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Similarly, NRPS modules have the domain order condensation (C), adenylation (A), peptidyl 
carrier protein (PCP), which serves the homologous function as ACPs (Figure 2). A domains, 
recognize and activate amino acids as aminoacyl-AMP intermediates which are then 
thioesterified to the PPant arm of the downstream PCP domain. The C domain catalyzes base 
abstraction of a hydrogen the upstream amide group and subsequent nucleophilic attack by the 
NH3 group of the PCP bound amino acid and chain elongation by the formation of a new peptide 
bond (10).   
 
Diversity in natural products is rapidly and easily accessed through atypical substrate 
incorporation during metabolite construction.  For PKS assemblies, this includes β-keto acids 
with variable substituents at the α-position, while for NRPSs the use of proteinogenic and 
nonproteinogenic amino acids, α-keto acids and other unique monomers account for the 
observed bricolage of NPs.  Structural heterogeneity is also achieved by elaborating the core 
biosynthetic modules through inclusion of in-line tailoring enzymes.  In PKSs these can include 
ketoreductases (KR), which catalyze stereospecific reduction of the β-keto group to either the (R) 
or (S) alcohol, dehydratases (DH) which, using the KR generated alcohol, form an α-β 
unsaturation in the growing chain and enoylreductase (ER) which reduce the DH product to the 
fully saturated alkane subunit (Figure 3).   
 
Figure 2.  Nonribosomal peptide synthetase  (NRPS) enzyme strategy A.  Adenylation (A) domain catalyzed activation of short 
amino acids as amino acyl-AMP and transfer to petptidyl carrier protein (PCP) B.  Intermodule interaction and condensation 





















































Auxiliary NRPS domains include epimerases (E), which convert the stereochemistry of the 
added amino acid (i.e. from D- to L-), methyltransferases (MT) which are responsible for 
addition of a methyl group to the growing chain, typically at the amide nitrogen, or distal 
heteroatom of the amino acid R-group and cyclases (Cy) which cyclize medium and long chain 
amino acids such as cysteine into thiazoline (12) moieties (Figure 4).  Additionally, the 
incorporation of both PKS and NRPS proteins within a single biosynthetic pathway, giving rise 
to a mixed system serves to further increase the number of small molecules that can be produced.    
 
The mechanism of termination is also a means by which structural variability is introduced 
during NP biosynthesis (13).  Off-loading of the growing chain is typically achieved by the 
functioning of a domain found at the C terminus of the final protein module.  Such enzymes 
include thioesterases (TE) which function as hydrolytic enzymes yielding a free acid, or 
catalyzing intramolecular cyclization generating either a macrolactone, as in pikromycin (14), or 
a macrolactam, observed in syringolin biosynthesis (15).  Reductases (Rd) can catalyze two-
electron reduction to release the NP as an aldehyde, observed in assembly of ET-743 (16), or the 
Rd can catalyze a four-electron reduction yielding an alcohol, as in myxalamid off-loading (17).   
 
 
Figure 3.  PKS reductive enzymes increase structural diversity in natural products.
Figure 4.  NRPS tailoring domains increase structural diversity in natural products.
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1.3 Moorea producens natural products 
Over the last two decades drug discovery efforts have begun to expand from terrestrial sources 
and into the aquatic environment (18, 19).  So-called bioprospecting has yielded a high number 
of metabolites with incredible structural diversity (20).  Largely, natural products have been 
isolated from both freshwater and marine invertebrates.  Of particular focus are natural products 
derived from marine cyanobacteria, from which over 300 nitrogen containing secondary 
metabolites have been reported (21).  Notable amongst blue-green algae is the filamentous 
cyanobacterium, Moorea producens (22), previously Lyngbya majuscula (23), as a prolific 
producer of bioactive metabolites.  These include the molluscicidal barbamide (24), protumor 
agent lyngbyatoxin (25), antifungal hectochlorin (26), neurotoxic jamaicamides (27), 
antimalarial carmabins (28), and the anticancer compound curacin A (12) (Figure 5). 
 
 
1.3.1 Curacin A is a potent antimitotic 
First isolated by Gerwick and coworkers in 1994, by bioassay-guided fractionation, the linear 
lipopeptide curacin A was shown to be active against both leukemia and lymphoma cancer cell 
lines, with a remarkable 3-fold greater potency than the clinically used plant natural product, 
vincristine (29).  As with other tubulin-targeting mitotic inhibitors (30), the cellular activity was 
determined to derive from G2/M transition arrest (31).  The inhibition of microtubule 
polymerization was determined to result from binding of the curacin A at the colchicine site on 
Figure 5.  Natural products isolated from the marine cyanobacterium Moorea producens. 
 6 
tubulin (31).  Moreover, Verdier-Pinard et al. (32) demonstrated that curacin A has an incredibly 
tight tubulin binding, with an immeasurable rate of dissociation.   Though the Kd suggested 
irreversible binding, denaturation of tubulin enabled release of the small molecule, indicating 
that a covalent modification does not occur. Curacin A does not chemically resemble any other 
molecules in this subclass of tubulin inhibitors, superimposition of MM2 calculated energy-
minimum configurations revealed structural similarities that represent a unique binding mode for 
colchicine-site occupying antimitotics (33).   
 
The structure-function relationship of the Curacin A was well studied by Wipf and coworkers 
(34, 35), who synthesized more than 60 analogues and examined each for tubulin polymerization 
inhibition (TPI50), competitive colchicine binding inhibition (CBI) and cell growth inhibition 
(CGI50) in MCF-7 cells.   Inversion of the stereochemistry of the cyclopropane, reduced the 
inhibition of colchicine binding by 46% as well as increased both TPI50 and CGI50.  Similar loss 
of activity was observed when cyclopropyl moiety was replaced with a tert-butyl functionality, 
however substitution with 1-butylene showed slightly decreased CBI, but a 7.5-fold increase in 
CGI50.  Interestingly, inversion of the stereochemistry of the diene core, especially at the C-3 
position Z-olefin, or chemical fragments of either the 2-methyl-cyclopropyl-thiazolinyl or the 





1.4 Curacin biosynthesis The biosynthetic origins of this intriguing natural product were 
collaboratively elucidated by the Sherman and Gerwick groups, a decade following its initial 
reporting (12).  Isotopic feeding studies, revealed that the molecule was derived from ten acetate 
units, two S-adenosyl-methionine derived methyl groups and one cysteine, suggesting that 
curacin A was the products of a mixed PKS/ NRPS system.  Indeed, screening of a cosmid 
library prepared from genomic Lyngbya majuscula DNA by shotgun sequencing led to the 
localization of an operon containing 15 open reading frames, curA-curN.  As a result of genome 
reassembly following 454 sequencing, the pathway was later revised (36), excluding the terminal 
module giving rise to the ~63kbp complete pathway consisting of ten PKS modules, and one 
NRPS module (Figure 6).    Deviations of the structure of the mature metabolite that were 
predicted based on pathway translation prompted interest into biochemically characterizing the 
enzyme responsible for two unique elements at either termini of curacin A. 
  



























1.4.1 β-branching cassette leads to 2-methyl-cyclopropyl ring formation.   
Inspection of the curacin pathway reveals four discrete domains between the first two PKS 
modules that share high sequence homology with proteins catalyzing the unusual isoprenoid-like 
β-branching transformations (37). This insertional biosynthetic array consists of 6 HCS cassette 
proteins hallmarks, 1) a stand alone ACP, 2) decarboxylating KS, 3) a 3-hydroxy-3-methyl-
glutaryl-CoA synthase (HCS) and two individually encoded enoyl-CoA hydratases (ECH), 4) 
one catalyzing dehydration, 5) and a second catalyzing decarboxylation and 6) an ACP multiplet.  
Unique to the curacin and the very closely related jamaicamide pathways are the incorporation of 
a halogenase (Hal) domain, and an unusual C-terminal flanking region (Cd) downstream of the 
tandem ACP array (38). 
   
Briefly, in the curacin system, CurD catalyzes the formation of HMG by condensing a CurB 
bound acetate, and the acetoacetyl-ACPI+II+III, derived from the loading and PKS catalyzed 
elongation of CurA.  The HMG-ACPI+II+III reengages with CurA to undergo halogenation, 
yielding 4-chloro-HMG-ACPI+II+III.  This is followed by ECH1, CurE, catalyzed dehydration 
giving rise to the 4-chloro-3-methylglutaconyl-ACPI+II+III and subsequently CurF-ECH2, 
catalyzed decarboxylation producing 4-chloro-3-methylcrotonyl-ACPI+II+III.  Cyclization is 
catalyzed by the unusual activity of the CurF-ER, which transfers hydride from NADPH, to the β 
position, leading to double bond electron rearrangement forming a new C-C bond and displacing 
































An investigation into the role of the unusual nonheme-Fe2+and α-ketoglutarate dependent 
halogenase, demonstrated that chlorination served as a crucial point of introducing structural 
diversity during curacin biosynthesis (40).  It was found ECH1-ECH2 coupled catalyzed 
dehydration-decarboxylation of 4-Cl-HMG-ACP was 4-fold faster than the non-chlorinated 
substrate.  Moreover, in the absence of the chlorine group, reaction with the ER catalyzed 
exclusive reduction of the 3-methylcrotonyl-ACP to the 3-methylbutanyl-ACP, thereby 
confirming chlorination to be indispensible for cyclization.   
 
1.4.2 Activation-elimination offloading strategy leading to olefin formation 
The biosynthetic origins of the unusual terminal alkene found in curacin A was illuminated by 
Gu et al. in 2009 (36). CurM includes an sulfotransferase (ST) domain integrated within the ACP 
and TE of the final module.  STs utilize 3'-phosphoadenosine-5'-phosphosulfate to catalyze 
sulfonation of alcohols or amines.  Within the context of the curacin pathway, the ST generates 
the β-sulfonic acid, from the corresponding KR produced (R)-β-alcohol.  Subsequent 
desulfonative-decarboxylation, catalyzed by the unusual function of the TE leads to alkene 
formation (Figure 8).  The use of a hydrocarbon-like substrate during this investigation suggested 



























1.5 Research outline 
Holistically, diversity in bioactive small molecules obtained from environmental sources, stems 
from unique modular architecture of a given pathway, which is emblematic of a type of naturally 
occurring “combinatorial biosynthesis”.  In this mode, a library of related small molecules can be 
generated from a single gene cluster enabling trends in structure and activity to be determined 
and evolutionarily optimized.  It stands then as a goal of natural product enzymologists, to make 
use of these biochemical processes in order to generate rationally designed, de novo small 
molecules in vivo.  One can imagine a system in which a chimeric biosynthetic pathway is 
assembled and used to produce a protein templated route, giving rise to an engineered “unnatural 
product”.  Ultimately what will enable us to achieve this goal, is an understanding of not only the 
standard biochemical “enzyme-ligand” domain-level interactions between substrate and catalytic 
partner but globally for enzyme megasynthases, an appreciation of the reigning regulatory 
mechanisms that control precise inter- and intramodular forces responsible for maintaining 
timing and order of protein communication throughout biosynthesis. 
 
Herein, are described two studies of noncanonical megasynthase biocatalytic transformations 
observed during the construction of curacin A as well as an initial survey of the biosynthetic 
origins of the cyanobacterial metabolite carmabin A.  Chapter two focuses on the unique β-
branching protein-protein interactions leading to the pharmacophore assembly.  The tandem 
carrier protein array as well as unusual C-terminal flanking domain are examined for their role in 
enhancing total biosynthetic turnover.  The third chapter covers research concerned with 
expanding modular enzyme function toward the development of a novel biofuels platform.  
Guided by the initial investigation of the terminal curacin module, the ACP, ST and TE domains 
from CurM were examined for substrate promiscuity and catalytic activity.  In addition, excised 
domains from a standalone cyanobacterial cluster containing shared ST-TE domain architecture 
were also studied. Chapter four includes a bioinformatic analysis of the newly identified pathway 
and partial biochemical characterization of cellular machinery responsible for alkyne formation 










Noncatalytic C-terminal protein domain enhances turnover during 
curacin β-branching  
 
2.1 Introduction 
Natural product structural diversification is typically achieved through the incorporation of 
variable elongation units and the downstream processing of the immature metabolite core (8).  
During polyketide synthase (PKS) biosynthesis, chemical elaborations are typically introduced 
into the final molecule through incorporation of functionalizations at the C-2 carbon of the 
incoming extender unit.  Several natural product systems have evolved a unique set of off-
pathway proteins that utilize the formation of a 3-hydroxy-3-methylglutaryl (HMG) group to 
broadly expand chemical structure (37) (Figure 9).  This protein cassette is defined by a core set 
of six proteins including an acyl transferase (AT), acyl carrier protein (ACPIV), keto synthase 
(KS) and HMG-CoA synthase (HCS), and two enoyl CoA hydratases (ECH).  Typically a carrier 
protein multiplet, consisting of two or more domains, is also observed. 
 
During elongation, the stand-alone AT transfers a malonate from malonyl-CoA to the 
corresponding ACP, followed by KS catalyzed decarboxylation.  The HCS catalyzes bifunctional 
condensation of an acetate group at the β-position substrate bound to the tandem ACP, followed 
by hydrolysis yielding the HMG.  The site specificity of the formation of this functional group 
provides the nomenclature for this type of “β-branching”.   The HMG undergoes successive 
dehydration and decarboxylation catalyzed by individual ECH domains.  This moiety can be 





Previously, the formation of the 2-methylcyclopropyl group found in curacin A (Cur) and the 
pendant vinyl chloride from the related jamaicamide (Jam) pathways were found to originate 
from an embedded HCS cassette in these two highly homologous pathways from the marine 
cyanobacterium Moorea producens (40). Interestingly, in addition to the HCS cassette, both 
systems, contain an embedded halogenase, which in the curacin pathway has been shown to be 
indispensable for the formation of the cyclopropane (Figure 10). Also unique to these pathways 
is a large 8kDa-flanking domain C-terminal (Cd) of the ACP triplet.  The Cd was demonstrated 
to increase total yield of a reconstituted β-branching assembly, by a greater than 2-fold increase.  
Experiments parsing the mechanism of this enhanced biosynthesis are the focus of this chapter.  
  





The highly conserved, HMG-CoA Synthase (HCS) assembly found in the curacin pathway was 
previously shown to produce the pharmacophoric 2-methyl-cyclopropyl moiety (38).  Briefly 3-
hydroxy-3-methyl-glutaryl-ACP is formed by a stand-alone HMG-CoA synthase by condensing 
acetyl-ACP and acetoacetyl-ACP.  Chlorination at the γ-position catalyzed by the embedded 
Halogenase (Hal), domain gives rise to the chlorinated substrate, which is critical for further 
modification by a dehydrating enoyl-CoA hydratase (ECH1), decarboxylating enoyl-CoA 
hydratase (ECH2).  Finally the modified enoylreductase (ER) catalyzes cyclopropane formation 
(Figure 10). Together these proteins constitute the isoprenoid-like β-branching assembly. 
 
 
A hallmark of this type of insertional cassette, also found in the bryostatin (41), viriginamycin 
(42), pederin (43) and bacillaene systems (44), is the presence of carrier protein multiplet, 
contrasted with canonical PKS and NRPS architecture, in which only a single thiolation domain, 
ACP or PCP, is present per module. Unique to the β-branching assemblies in the Cur and Jam 
systems, which possess a carrier protein triplet with 94% sequence identity (Figure 11), 
ACPI+II+III, is the presence of 8 kDa C-terminal flanking domain (Cd), 71.2% pairwise identity 
(Figure 12), giving rise to the unusual tetradomain ACPI+II+III+Cd.  
 
 
Figure 10.  Curacin A 2-methyl-cyclopropane is formed by ß-branching protein.   Cycloporanation is the result of interactions 
between the ACPI–II–III-Cd, and Hal, ECH1, ECH2, and ER.  See text for domain abbreviations.
*
Figure 11.  Sequence alignment of excised ACP domains from the CurA and JamE carrier protein multiplets.  Asterisk 




2.2.1 Cd increases biosynthetic flux of a reconstituted β-branching system 
In order to determine the functional role of the Cd domain, a series of carrier protein constructs 
were prepared.  Proteins were designed varying the number of ACPs as mono-, di-, tridomains, 
as well as Cd truncations lacking the terminal domain.  Additionally, carrier protein knockouts, 
with the active site serine mutated to alanine preventing substrate loading were also generated, in 
order to examine whether the ACPs are capable of functioning in parallel or whether 
transformation occur in series, as observed in polyunsaturated fatty acid biosynthesis (45).  
Proteins were overexpressed, purified and loaded with (S)-HMG to generate the (S)-HMG-ACP 
substrate.  The carrier proteins were incubated in one-pot reaction along with the Hal, ECH1, 
ECH2, ER and NRPS domains from CurF.  As a metric of complete processing of the HMG by 
both the β-branching enzymes as well as NRPS module, 2-methyl-cylcopropyl-thiazolinic acid 
was released from the PCP via base catalyzed hydrolysis and quantified via LC-MS (Figure 13) 
(38).   
 
 
For a single excised carrier protein, approximately 10% conversion was observed.  Doubling, the 
number of ACPs, prepared as either ACPI+II or ACPII+III, yielded a stoichiometric increase in 
conversion, 18-24%, while the tridomain, ACPI+II+III, led to 37% overall yield.  For the ACP 
Figure 12.  Sequence alignment of the terminal C-terminal flanking domains, Cd,  from the CurA and JamE carrier protein 
multiplets.
Figure 13.  Schematic for one-pot reaction and metabolite analysis.  Characterization of ß-branching interaction and effect of 
ACP isoform on 2-methyl-cyclopropyl-thiazolonic acid formation.
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knockouts, yields of thiazolinic acid were proportional to the number of competent ACPs; double 
mutants, converted the substrate to near 10%, while the single mutants performed between 19-
25%.  These numbers were consistent with excised mono- and didomain constructs indicating 
that the ACPs were capable of functioning independently.  Unexpectedly, the addition of the Cd 
domain to the ACP triplet, ACPI+II+III+Cd, was capable of increasing the conversion of HMG-ACP 
to 2-methyl-cylcopropyl-thiazolinic acid 2.7-fold to 100%, relative to the construct lacking the 
Cd.  Similarly, the rate enhancement was also observed for ACP double knockouts possessing 
the Cd with increased rates of conversion 2.6-3.0-fold when the Cd was present. 
 
2.2.2 Biophysical characterization of Cd on protein dynamics 
Our first insight into how these proteins might be acting in order to increase the total turnover 
came during the purification process.  ACPI+II+III and ACPI+II+III+Cd were prepared as highly 
concentrated samples and were loaded onto a Superdex Gel filtration column in order to further 
purify protein samples by size exclusion chromatography (SEC).  Unusually, both proteins eluted 
at a volume corresponding with a size of approximately 1.25-2 the expected molecular weight 
(Figure 14).  Analytical gel filtration confirmed that ACPI+II+III had an apparent molecular weight 
of 63.1±.5 kDa, while the ACPI+II+III+ had eluted at a volume corresponding with 106.6±7 kDa.  
 
Excised ACP constructs showed similar increases in apparent Concentration molecular weight 
(Table 2).   Though differences between observed and calculated molecular weights increased 
with the number of ACP domains present, the greatest proportional increase was affected by the 
presence of the 8kDa Cd.  This phenomenon appeared to be concentration independent, as no 
Figure 14.  Analytical size exclusion chromatography for CurA ACP multiplets.  Concentration independence of apparent 
molecular weights increases for ACPI+II+III and ACPI+II+III+Cd.  Traces were recorded at 280nm.  Green trace- 10mg/ml; Blue 
trace- 5mg/ ml; Red trace- 2 mg/ ml.
ACPI ACPII ACPIIIACPI ACPII ACPIII cd
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change in the apparent molecular weight for either ACPI+II+III or ACPI+II+III+Cd was observed over a 
range of sample concentrations (Figure 14).   
 
These findings suggested that unlike ACPs from canonical PKS or fatty acid synthase systems, 
which are monomeric (46), the unique tandem carrier proteins found in the Cur β-branching 
cassette may exist in equilibrium with a higher order protein oligomer. 
 
The apparent stabilization of a Cd mediated, ACP-triplet quaternary structure, was further 
investigated using, biophysical methods.  Analytical ultracentrifugation (AUC) has been used to 
determine the shape and binding stoichiometry of proteins by monitoring sedimentation of the 
macromolecule under high centrifugal force, over time (47). The purified ACPI+II+III and 
ACPI+II+III+Cd were prepared at three different concentrations and analyzed independently by 
sedimentation velocity.  By AUC both ACP constructs appeared to be prolate ellipsoids, with 
frictional coefficients ranging from 1.47-1.53 (Table 3).  The observed molecular weights were 
determined to be 36.7±0.8 kDa and the 42.0±1.9kDa, for ACPI+II+III and ACPI+II+III+Cd, 
respectively, indicating that both proteins were monomeric in solution. 
ACP construct Calculated MW, kDa Observed MW, kDa 
ACPI 10.9 13.1± 0.5
ACPII 11.3 14.2± 0.5
ACPIII 11.0 13.2± 0.7
ACPI–ACPII 23.6 42.3± 2.5
ACPII–ACPIII 22.6 40.7± 2.0
ACPI–ACPII–ACPIII 36.0 63.1± 5.1
ACPI–ACPII–ACPIII–Cd 44.6 106.6± 7.3
Table 2.  Apparent molecular weights of ACPs by analytical gel filtration chromatography.
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Though this finding is incongruous with the results of the SEC, previous investigations into 
protein stoichiometry have demonstrated the susceptibility of weak oligomeric interactions to be 
disrupted by the high hydrodynamic pressure generated by AUC conditions (48); thus we sought 
to undertake a direct inspection of the oligomeric state of the protein by electron microscopy 
(EM).   ACP constructs were purified to homogeneity by preparative gel filtration and diluted to 
a uniform concentration.  Samples were then loaded on a carbon grid and overlaid with uranyl 
formate to enable visualization by negative staining.  Individual particles were selected, binned 
and sorted according to class averages (Figure 15).  For the ACPI+II+III, the protein population was 
determined to be 74% monomeric and 25% dimeric, while for the ACPI+II+III+Cd, the distribution 
was 29% monomeric and 70% dimeric.  This mixed population of ACPs detected by EM 
supported the hypothesis that the Cd mediated shift in the ACP self-association equilibrium 
towards the dimer, was a possible explanation for the observed increase in yield.   
Protein(Construct ACPI–II–III ACPI–II–III-Cd
Sed.(Coeffi.,(10-13 s 2.58±&0.04 2.74±&0.03
f/f(0) 1.47±&0.02 1.53±&0.05
Observed(MW,(Da 36788±&830 42035±&1964
Calculated MW, Da 36702 44614




2.2.3 Preliminary characterization of Cd catalyzed self-association  
As demonstrated by negative staining, the Cd shows an effect on shifting the protein equilibrium 
of the ACP triplet towards dimerization.  In order to calculate the binding constants afforded 
exclusively by the Cd, the 8kDa region was cloned and overexpressed as an excised domain.  
This purified fragment was concentrated to >600 µM, in order to obtain as much of the Cd-dimer 
as possible.  Dilution experiments were carried out by isothermal titration calorimetry (ITC) with 
the Cd, by injecting small volumes of the concentrated protein into a sample-cell containing only 
buffer.  Heats of dilution were plotted against mole fraction buffer and the curve was fitted to a 
simple two state equilibrium with an apparent Kd of 1.96±0.11 mM (Figure 16).   
Figure 15.  Electron microscopy analysis of CurA ACP multiplets by negative staining.  2D class averages and raw data (inset) 




The extraordinarily high value of this dissociation constant, which extends beyond the 
experimental range, suggested that additional domains might be necessary to observe Cd 
functioning as a dimerization domain.  To examine this, wild type constructs of the ACPI+II+III and 
the ACPI+II+III+Cd were prepared and concentrated to >200 µM, a concentration above which the 
protein is prone to precipitation.  Again, dilution experiments were performed with Kd values of 
1.78±0.2 mM and 1.88±0.2 mM obtained.  While the absences of significant heats of dilution 
were consistent with the previously obtained results for the excised Cd domain, the origin of the 
enhanced binding affinity observed during the EM analysis remained elusive.    
 
2.2.4 Mechanistic insights into cyclopropane formation by individual reaction monitoring  
Through negative staining and analysis by EM, we demonstrated that the Cd was capable of 
shifting the oligomerization equilibrium of the CurA ACP triplet towards the dimer.  However, 
we sought to examine the physiological role of the Cd in facilitating enhanced biosynthetic flux 
μcal/ injection v. Monomer concentraton, Cd
Figure 16.  ITC dilution assay for the CurA Cd.  Heats of injection of concentrated Cd dimer, diluted into buffer, and plotted 
against fraction monomer.
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by looking at discrete reactions along the Cur β-branching pathway.   
 
Interactions between megasynthases are dictated by short, protruding regions adjacent to the C-
terminus and N-terminus of the donor and acceptor modules, respectively.  PKS docking 
domains (dd) and NRPS communication domains (com) maintain not only specificity of the 
modular protein-protein interactions but also efficient transfer of substrate (49-52).  Global 
alignment of the docking domains within the Cur pathway revealed two unique docking 
interfaces between the β-branching modules, CurA-CurF, as well as between CurF-CurG at the 
NRPS-PKS interface.  Such conspicuous dissimilarities in sequences, led to the hypothesis that 
the Cd might function in a novel, β-branching specific, docking mode.  While the Cd has only 
been identified in Cur and Jam systems, sequence alignment of β-branching modules that 
terminate in an ACP multiplet revealed a 34 amino acid region with 27.8% sequence similarity 
for the C-terminus of the donor module, and 24 N-terminal amino acids with 36.4% sequence 
similarity derived from the ECH2 of the down stream acceptor module, supporting the role of the 
Cd in modular docking interactions. 
  
To examine the role of the Cd in enabling specific protein interactions, constructs of the terminal 
carrier protein lacking or possessing the Cd, ACPIII or ACPIII+Cd, respectively, were generated.  
ACPs were overexpressed and purified in the apo-form and confirmed by MS.  Proteins were 
then loaded with (R, S)-HMG-CoA using the phosphopantetheinyl transferase, Sfp.  Individual 
reactions were monitored stepwise by protein mass spectrometry.  Herein, reaction aliquots were 
quenched at various time-points with the addition of the formic acid at a concentration sufficient 
to denature, but not precipitate the proteins.  Unlike the previous investigation of the β-branching 
assembly however, the substrate was not hydrolyzed from the ACP, rather the proteins were 
subject to inline LC-MS in order to analyze modifications to the HMG substrate (Figure 17). 
Additionally, as the preferred stereochemistry of the Hal and ECH1 substrates are known to be 
(S)-HMG, maximal rates of conversion are expected to be 50% resulting from racemic mixture 





2.2.4.1 Cd dramatically increases rate of halogenation 
We have previously demonstrated that Hal requires Fe2+ and α-KG as cofactors to generate γ-
chloro-HMG.  In order to provide holo-halogenase, Hal was incubated with freshly prepared 
(NH4)2Fe(SO4)2 and α-KG prior to the addition of ACP-loaded substrate.  The reactions were 
initiated with the addition of HMG-ACP, and extent of chlorination was analyzed by mass 
spectrometry.  For the excised ACPIII construct, chlorination occurs, with 26.0% conversion by 5 
minutes, and only 45.1% converted in 30 minutes.  Remarkably, for the ACPIII+Cd, 27% is 





































Figure 17.  Examination of discrete ß-branching interactions by LC-MS.  Schematic of individual or combinations of reactions 
catalyzed upon incubation of HMG-ACP with excised domains.  Rates of conversion were determined by both deconvoluted 
mass abundance as well as comparison of charge states for ACP modifications
Abundance 4-chloro-HMG-ACP v. Time














Figure 18.  Cd dramatically increases rate of halogenation of HMG-ACP.  Black circles- ACPIII. Blue circles- ACPIII-Cd
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2.2.4.2 Cd does not affect rate, but increases extent of dehydration 
To obtain 100% concentrations of the 4-chloro-HMG-ACP substrate for dehydration, the 
reactions were prepared as for the halogenation reaction, and allowed to react for 45 minutes 
prior to the addition of the ECH1.  Difficulties in obtaining sufficiently pure and active CurE 
ECH1 led us to use JamI ECH1 as a surrogate dehydratase.  The rate of formation of 4-chloro-3-
methylglutaconyl-ACP for both ACP isoforms was incredibly rapid and the maximal conversion 
achieved within 60 seconds FIG, though a slight increase in the total abundance of the 
dehydrated product is observed for the Cd containing construct, 14.0% versus 15.8% (Figure 19).  
 
 
Unexpectedly, the majority of the 4-chloro-HMG-ACP remains unreacted for both the ACPIII and 
the ACPIII+Cd (Figure 20).    The origins of apparent reaction stalling are unknown, though it is 
possible that the reaction is reversible and sensitive to the presence of the downstream catalytic 
proteins. 
 

















Figure 19.   Effect of Cd on ECH1 activity.  Cd does not effect rate, but increases extent of dehydration of Black circles- 




2.2.4.3 Cd does not effect rate, but increases extent of decarboxylation 
As with dehydration, no substantial differences in the rate of decarboxylation were observed 
(Figure 21) upon addition of the ECH2WT, however 4-chloro-3-methylcrotonyl-ACPIII+Cd was 
1.5-fold more abundant, 23.8% v. 36.0%, than for the ACPIII by the end of the reaction.  
Similarly with the ECH1 catalysis, decarboxylation of substrate does not go to completion for 
either ACP construct  
 
 
2.2.4.4 ECH2 N-terminus has minimal effect on rate of decarboxylation 
To determine the potential effect of the CurA-CurF docking interaction, an N-terminally 
truncated ECH2dd was generated lacking the first 15 amino acids.  For the ACPIII, a slight 
increase in the total amount of the 4-chloro-3-methylcrotonyl product was observed, however 
















Distribution of ACP isoform following dehydration, ACPIII















Figure 20.  Evaluation of ACP isoform following ECH1 interaction.  As evidenced by the presence of chlorinated substrate, 
dehydration is incomplete and independent of Cd.  Black circles-  HMG-ACP.  Blue squares 4-chloro-HMG-ACP.  Green 
triangles- 4-chloro-3-methylglutaconyl-ACP

















Figure 21.  Effect of Cd on ECH2 activity.  Extent of decarboxylation is incomplete and dependent of Cd.  Black circles- 
ACPIII. Blue squares -ACPIII-Cd.
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this number is within error of that observed for the ECH2WT, while no differences in either rate 
or extent of decarboxylation were observed for the ACPIII+Cd construct (Figure 22).   
 
 
2.2.4.5 Cd does not effect rate, but increases extent of cyclization 
The effect of the Cd on ER catalyzed cyclopropanation, followed a similar trend as observed 
with the remaining β-branching proteins.  The maximal conversion of 2-methyl-cyclopropane 
was achieved rapidly for both the ACPIII as for the ACPIII+Cd, while the total yield was 1.3-fold 






































Figure 22.  ECH2 activity is independent of N-terminal docking domain and presence of Cd.   Blue squares- WT ECH2.  Black 
squares- docking domain-less ECH2
















Figure 23.  Effect of Cd on ER activity.  Extent of cyclopropanation is incomplete and dependent of Cd.  Black squares- 
ACPIII. Blue triangles -ACPIII-Cd.
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2.2.4.6 Reconstitution of β-branching cassette in a one-pot reaction 
In assessing the sum function of the enzymes in the conversion of HMG to 2-methyl-
cyclopropane, the β-branching cassette was reconstituted in a one-pot reaction mixture.  Hal, 
ECH1, ECH2WT, and ER were incubated for 10 minutes along with the necessary Hal cofactors 
as well as NADPH, required for ER functionality.  Reactions were initiated with the addition of 
HMG-loaded ACP.  Over the time course of the reaction, 1.2-fold greater cyclopropyl-ACP was 
formed for the Cd containing construct 35.3±1.3%, whereas 28.8±6.1% was generated for ACPIII 
(Figure 24).  Additionally, the rate of conversion is also faster of the ACPIII+Cd, suggesting 
halogenation is a critical rate-determining step.    This trend of increased conversion is in 




Global analysis of all ACP isoforms (Figures 25, 26) over time revealed a rapidly formed 
substrate pool of the chlorinated and dehydrated species that is converted to the cyclopropane by 
the ER.  For the ACPIII, 5.5±1.1% 6.7±0.5%, of the chlorinated and dehydrated products were 
detected, while for the ACPIII+Cd, slightly more 4-chloro-HMG-ACP 9.5±0.5%, was detected 
compared with the Cd-less construct, while a moderate decrease in the dehydrated 4-chloro-3-
methylglutaryl-ACP, 6.0±0.4%, was observable.  Interestingly no decarboxylated product is 


















Figure 24.  Effect of Cd upon ß-branching reconstitution.  Extent of cyclopropanation is evidenced by the increase in tottal 
abundance and rate of cylopropane formation.  Black circles- ACPIII. Blue squares -ACPIII-Cd.
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detectable for either ACPIII or ACPIII+Cd, suggesting the rapid conversion of the 4-chloro-3-






Form these experiments, a more complete understanding for cyclopropane formation can be 
developed, wherein individual domains each play a critical role in the biosynthesis of the unusual 
structural moiety (Figure 27).   
Figure 25.  Distribution ACP isoform over time in the one-pot assay cyclopronation assay, ACPIII ,+9 charge state.  See text for 
discussion.








2.2.5 Solution structure of ACPI and characterization of Hal-ACP interaction by MS 
The unusually high sequence identity shared between the CurA and JamE ACP triplet, and the 
significant role of the unusual halogenase as part of the β-branching cassette in pharmacophore 
biosynthesis led us to structurally probe ACP dimerization and ACP-Hal interactions (53). 
 
15N-labeled ACPI+II+III and ACPI+II+III+Cd were prepared and used to study the self-association of the 
carrier protein triplet.  To account for the large size of the protein transverse relaxation optimized 
spectroscopy (TROSY), rather than heteronuclear single quantum coherence spectroscopy 
(HSQC) was employed, and [15N, 1H]-TROSY spectra were recorded for both isoforms of the 
ACP triplet.  Addition of Cd led to minor decreases in peak intensities overall, however no 
differences in chemical shifts for the core helices were detected, as compared with the construct 
lacking the domain.  This result suggested that the ACPs adopt a uniform conformation 
independent of the presence of the Cd.  In order to detect discrete domain-domain interactions 
resulting from protein dimerization, titration experiments were carried out using 15N-labeled 
excised ACPI monodomain, or ACPI+II or ACPII+III didomain constructs, and incubated with 15N-
ACPIII and similarly examined as for the full tridomain.  To our surprise no perturbations in 
chemical shifts were observed for titration of any combination of the proteins, suggesting the 
intra-ACP-domain interactions do not occur. 












































Figure 27. Role assignment for individual ß-branching reactions during cyclopropane formation based on LC-MS analysis.
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The solution structure of the excised ACPI was solved by NMR and shown to be a right-handed 
twisted bundle, comprised of four α-helical domains.  Typical, carrier proteins contain three 
helical domain, however the somewhat longer, highly hydrophobic interloop region between 
helices αII and αIV, was ordered and adopted a helical conformation.  The unexpected lack of 
structural differenced of the ACPs when dimerized, prompted us to examine the potential for 
substrate mediated conformational changes that take place for an excised ACP.  Indeed, 
conversion of the ACP from the apo- to the holo- form via in vitro phosphopantetheinylation 
showed the peak of the invariant active serine, Ser1989, has a substantial downfield shift from 
9.0 to 8.5ppm suggesting modest structural rearrangement to accommodate the PPant prosthetic 
group.  However carrier proteins subsequently prepared as, HMG-loaded or, 4-Cl-HMG-loaded, 
or as the nonnative acetyl-loaded, only exhibited minor shifts surrounding the PPant.   
Perturbations in chemical shifts were greatest for residues in proximity to the active site, 
specifically, A2009, V1983, I1990, D2014, and D1988, presumably to account for the increase 
in substrate bulk of the loaded as compared with the holo- protein.   
 
An examination of these residues in enabling specific Hal-ACP interactions was carried out by 
mutagenesis and comparing the ratio of 4-chloro-HMG-ACPI: HMG-ACPI for each mutant 
relative to wild type.  Initially these measurements were collected by MALDI-TOF, however, 
signal broadening and peak overlap led us to utilize LC-ESI-QTOF (Figure 28).  This technique 
enabled quantification of protein activity by simultaneous integration of HPLC peaks of the 
separated proteins, as well as by charge abundance for the chlorinated and non-chlorinated 
proteins.   
 
Though differences in activity vary between analytical methods, consistently, the most 
deleterious point mutants were constrained to the area surrounding the active site serine.  The 











































































































































































































































































































































































































































































































































































2.2.6 Interrogation of Hal-ACP interaction by computational docking 
To further our understanding of the ACP-Hal interactions a docked model of the proteins was 
prepared using the online server Hex (54).  The crystal structure of the closed form-halogenase 
containing the Cl-, Fe2+ and α-KG cofactors (PDB- 3NNF) (55), was used as the receptor ligand, 
while the NMR structure of the HMG loaded-ACPI (PDB- 2LIW) (53) was used as the ligand 
protein.  Residues identified from the ACP activity used to guide the investigation of ACP-Hal 
interactions that are effected by mutagenesis. 
 
The ACP active site serine, on the interhelical loop between α1-α2, is angled directly into the 
Hal active site, sitting below the Hal lid (Figure 29). The distance from the serine to the chlorine 
density is approximately 25Å, within reason for a fully extended HMG-PPant to interact in the 
Hal active site.  Interestingly Hal R279 sits directly over the ACP Ser1999 which likely functions 
to stabilize, via charge complementation, the PPant phosphate (Figure 30).   
Figure 29.  Computationally docked model for CurA Hal and ACP.   Cyan- Hal.  Pink- Active site lid.  Blue sphere- active site 
iron.  Red sphere- active site chlorine.  Wheat- ACP,  Salmon- active site serine.  See text for details. 
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Extensive salt bridging interactions and hydrogen bonding are observable between the docked 
proteins.  Readily apparent is the direct interaction of ACP D1988 and Hal K282 (Figure 31), as 
well H-bonds formed between the conserved ACP YDY2013-2015 on the C-terminus of ACP α3 
forming with side chains from Hal Q45, K275, and R272 (Figure 32).   
 
 
Figure 30.  Computationally docked model for CurA Hal and ACP.  Figure 30.  ACP-Hal active site interaction.  CurA ACP projects into the Hal active site.  Hal R279 is positioned over the ACP active site likely interacting with the ACP prosthetic group. 




The effect of mutations on ACP α2 and the N-Terminus of ACP α3 are likely the results of 
perturbations to the densely packed hydrophobic network (Figure 33).  Insertion of the large 
bulky side chain as in the A2009R mutant also likely effects the presentation of the substrate to 
the halogenase.  It is apparent, that surface contacts between CurA ACPs active site and Hal play 
an important role for inter-domain recognition and catalysis, though a discrete function and the 
specific contacts enabled by Cd remains elusive.   
Figure 32.   ACP hydrogen bonding is disrupted in site directed mutants.  Highly conserved Y-D-Y, residues 2013-15 engage 




2.2.7 Putative structure of the Cd resembles PKS docking domains 
As a complement to the docking study, the putative structure of the Cd was determined by 
ITASSER structural prediction.  Comparison of the Cd, with PKS dd and NRPS com show the 
high degree of structural similarity of the Cd with the helix-loop-helix architecture of the 
erythromycin docking domains (50, 56), as contrasted with the communication domain from 
tubulysin pathway (52).  
 
Figure 33.  Tightly packed hydrophobic network on the ACP is disrupted by mutation.
A. B. C.
Figure 34.   Structural comparison of donor modules from intermodular system.  A. CurA Cd.  B. PKS-DEBS2 docking 
domain.  C. NRPS- TubC communication domain.
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2.3 Discussion 
While β-branching systems are not common, they are by no means rare in natural product 
biosynthesis.  The six core HCS cassette proteins also appear as biosynthetic components of 
other NPs such as virginamycin (Streptomyces), myxovirescin A (Myxococcus), bacillaene 
(Bacillus), bryostatin and mupirocin (Pseudomonas), each resulting in a distinct structural 
moiety.  The Cur and Jam systems are unique in that inclusion of an additional catalytic domain, 
Hal, is critical for generating either the 2-methyl-cyclopropyl group or vinyl chloride, 
respectively.  Additionally, the presence of C-terminal ACP flanking domain, Cd, conspicuously 
present exclusively in the Hal containing pathways drives the question of whether these domains 
are engaging in specific intramodular protein-interactions as a means of passing substrate back 
up-stream following modification by the HMG-CoA synthase.   
 
As demonstrated during the NMR titration experiments, individual ACP domains do not interact.  
This finding would portend of independently functioning carrier proteins domains as the full-
length triplet.  Consequently, presence of a somewhat large portion of dimeric ACP triplet, 
lacking the Cd domain observed by EM is perplexing.  The presence of dimeric proteins can 
potentially be explained by considering the conditions under which the ACPs were prepared.  
Using the previously published protocols for overexpressing  ACPs, that is in unbuffered media 
lacking Fe2+ and an overexpression time of greater than six hours, undoubtedly a fraction of ACP 
phosphopantetheinylated.  Given the absence of reducing agent from the purification buffers, and 
the significant amount of time proteins are exposed to air during prior to EM analysis, it stands to 
reason that a significant portion of PPant disulfide could easily have formed.   Additionally, the 
construct of ACPI+II+III that was used for EM analysis possessed a serine to alanine mutation for 
the ACPII, thus one third of the potential active site modifications could not occur and this may 
account for the decrease in disulfide formation. 
 
The elongated structure of the protein, as determined by AUC measurements might also be 
useful in understanding the unusual SEC profile of the ACPs.  Molecular weight calculations by 
Gel-filtration or Gel-permeation chromatography are predicated based on the construction of a 
standard molecular weight plot.  For macromolecules, proteins or protein complexes, are 
assumed to run as globular, sphere-like proteins.  Indeed, analytical size exclusion 
 38 
chromatography performed on the tandem ACP-array from PUFA biosynthesis, which has no 
Cd-like domain, demonstrated a similar, greater-than-expected molecular weight elution profile; 
excised carrier proteins were shown to elute at 1.69-2.68-fold greater than expected, while the 
pentadomain eluted at a volume equal to 2.98-fold greater molecular weight (57).  Moreover, the 
small angle X-ray scattering (SAXS) derived mode for the tandem ACP, reveals that the fused 
proteins are overall monomeric and that the flexible interdomain linkers enable autonomous 
functioning of individual ACPs.  The increase apparent hydrodynamic volume, resulting from of 
the beads-on-a-string conformation, can also be used to explain differences between the expected 
and observed analytical chromatography profiles for each of the ACPs.  This type of domain 
mobility is also observed under negative stain conditions with the Cur ACP triplet, suggesting 
that the inherent protein flexibility may also play a role in the functioning of those proteins and 
the lack of substantial binding affinity as determined by NMR titration and ITC, though validity 
of significance of the dissociation constant obtained by dilution experiment is questionable given 
that the fitted data extend outside the tested range.   
 
The strongest support for functional role of Cd comes from a consideration of the stepwise 
formation of the 2-methyl-cylclopropane.  Halogenation rates appeared to be the only reaction 
during which the Cd demonstrated a significant effect, though minor differences in the 
proportion of reactant ACP proceeding towards dehydration and decarboxylation were observed.  
An experiment can be designed in order to dissect the potentially enhanced Cd mediated 
interaction with ECH1, catalyzing the reversible dehydration reaction.  Carrying out the HMG-
ACP, Hal and ECH1 reaction in H218O and using a highly resolving mass spectrometer (i.e. FT-
ICR-MS) the equilibrium between the proteins species could be examined. If the reaction were 
demonstrated to be reversible, the hydroxyl group on the HMG would carry a 2 Da increase in 
mass, resulting from the heavy oxygen, while modifications could similarly be localized to the 
phosphopantetheine bound substrate using the PPant ejection assay. Rates of formation could 
then be correlated to enhanced interaction for the ACPIII or ACPIII+Cd.  A possible explanation for 
the lack of observed difference in activity of the WT and N-terminally truncated ECH2 is the 
unusual quaternary structure of the excised domain.  ECH2 was demonstrated to be trimeric (58) 
in solution, rather than the prototypical dimer for PKS proteins.  The addition of this third 
domain may be sufficient to mask any effective increase in the presence of the Cd.  The 
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oligomeric state of the ECH2 has been shown to be concentration dependent, and thus running 
the reactions at a lower concentration of decarboxylase may reveal previously undetected 
differences in conversion. 
 
A direct quantification of the affinity of ACPs for self association and β-branching proteins can 
be examined using a variety of methods including fluorescence polarization, surface plasmon 
resonance or biolayer interferometry, which would provide conclusive evidence as to the origins 
of biosynthetic flux increases associated with the Cd.   
 
2.4  Materials and methods 
Bacterial strains, media and culture conditions. 
Escherichia coli DH5α subcloning efficiency cells (Invitrogen) were used as axenic stocks for 
the preparation of electrocompetent cells for DNA propagation and maintenance.  Escherichia 
coli Rosetta BL21(DE3) (Novagen) harboring the pRARE plasmid (spectinomycin resistance 
exchanged for chloramphenicol by Dr. W. Clay Brown, University of Michigan) for general 
protein overexpression; holo- carrier proteins were obtained using the BAP1 cell line (Pfeifer). 
All transformations were achieved via electroporation (BioRad, Gene Pulser Xcell), with 2.5-500 
ng DNA from ligation reaction mixture or as intact plasmid, recovered with SOB, allowed to 
outgrow for 60 minutes prior to plating on lysogeny broth-Miller-agar plates (LB-Miller) 
supplemented with the appropriate antibiotic (ampicillin- 50 µg/mL, kanamycin- 50 µg/mL, 
spectinomycin- 25 µg/mL). 
 
Protein overexpression, media and culture conditions 
Fresh transformants harboring the plasmid of interest were used to inoculate a culture of 
lysogeny broth-Miller (LB-Miller), corresponding with plasmid resistance marker (ampicillin- 
50µg/mL, kanamycin- 50µg/mL, spectinomycin- 25 µg/mL).  Overnight (~12-18 hours) cultures 
were used to subinoculate (1:100 (v/v)) large-scale (500-1000 mL) cultures supplemented with 
appropriate antibiotics for protein overexpression.  Apo- carrier proteins were cultured in LB-
miller supplemented with 1% (v/v) Glycerol, 25mM Tris (pH= 7.5), and freshly prepared 100 
µM Fe(II)SO4. ECH1 was grown in 2XYT, while Hal, ECH2WT, ECH2dd, ERΔ2 and Sfp were 
all grown in LB-Miller.   
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For all proteins of interests, large-scales cultures were grown at 37° while shaking at 160 RPM 
until reaching an OD600 0.6-0.8.   Flasks were allowed to cool at room temperature for 20-30 
minutes.  Protein overexpression was induced with the addition of isopropyl-β-D-
thiogalactopyranoside (IPTG) to a final concentration of 0.2 mM.  Flasks were returned to a 22° 
shaker and continued to grow to lower the temperature of the incubator by 2 degree increments 
over 20 minute intervals until a final temperature of 18° was reached. Carrier proteins were 
harvested following 5 hours induction, while Hal, ECH1, ECH2WT, ECH2dd, ERΔ2 and Sfp 
were allowed to grow for 12-16 hours prior to harvesting.  Cells were harvested by centrifugation 
at (5000xg, 10 minutes, 4°), transferred to 50mL Falcon tubes and cell pellets were flash frozen 
in liquid nitrogen and stored at -80° until purification. 
 
Protein purification 
All steps during the protein purifications were performed at 4°.  Cell pellets were resuspended in 
2x cell volume (minimum 25mL) 5-10% Buffer B, and incubated with freshly prepared 
lysozyme (0.2 mg/mL final, prepared in MilliQ H2O), freshly prepared PMSF (1 mM final, 
prepared in DMSO) and 0.5 cOmplete protease inhibitor cocktail (Roche) tablet for 30 minutes 
while rocking.  Cells were lysed by use of a recently tuned ultrasonic dismembrator with 5 cycles 
of 2 minutes, with pulses of 3 seconds on, followed by 3 seconds off, with intensities ranging 
from 7-8.  All cycles were carried with chilled beakers in packed ice bucket.  Cellular debris was 
removed by centrifugation at 40000-50000xg for 30 minutes and the supernatant was transferred 
to a fresh tube.; residual insoluble material was removed by filtration (syringe driven 0.45 µm 
filter) or a second round of centrifugation.   
 
Immobilized metal affinity chromatography  
The first step to purifying all proteins made use of the affinity of the His-tag towards divalent 
cations.  Clarified lysate was applied to 2 mL nitrolotriacetic acid-agarose resin (Qiagen), 
charged with Ni2+, and equilibrated with 10% Buffer B.  The resin was washed extensively with 
25 column volumes of 15% buffer B to remove any nonspecifically bound proteins.  The target 
protein was eluted with a stepwise gradient from 20-100% Buffer B.  Peak fractions as 
determined by gradient SDS-PAGE ((4-12%) (Novex NuPage) run in MES buffer at 180 mV for 
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50 minutes) were pooled and concentrated using Amicon ultra centrifugal concentrators 
(Millipore, 0.5 kDa, 3 kDa, 10 kDa), equilibrated with Buffer F until a volume of 2.5 mL was 
reached.  Proteins were buffer exchanged with a PD10 washed and equilibrated with Buffer F 
and eluted with 3.5 mL of Buffer F.  Proteins were further concentrated to less than 100-500 µL, 
aliquoted, flash frozen in liquid nitrogen and stored at -80°.  
 
Analytical Gel Filtration  
Proteins used for FP, ITC and EM analysis were further purified by size exclusion 
chromatography.  Concentrated aliquots were loaded onto a Superdex 200 10/300 GL (GE 
Healthcare) equilibrated with either Buffer F (FP) or Buffer G (ITC, EM).  Fractions were 
analyzed for purity by SDS-PAGE, concentrated, aliquoted flash frozen in liquid nitrogen and 
stored at -80° for FP and EM; proteins used for ITC were dialyzed (1:4000) against freshly 
prepared Buffer G and subsequently concentrated and stored.  Protein concentrations were 
determined using the bicinchoninic acid assay (BCA Pierce) according to the manufacturers 
guidelines, using a BSA standard curve and read in 96 well format.   
 
Analytical Ultracentrifugation.  
ACP3 and ACP3-CD were analyzed by sedimentation velocity in 50 mM Tris, 200 mM NaCl, 
5% Glycerol at 0.2, 0.5 and 0.8 mg ml-1 using a ProteomeLab XL-I (Beckman Coulter). Samples 
were loaded into sector-shaped double channel centerpieces and spun at 42,000 rpm in an 
AN50TI rotor and 22 °C. Absorbance scans were collected continuously at 280 nm and a radial 
resolution of 40 µm and 3 replicates. Data analysis was with the enhanced van Holde-Weischet 
analysis module followed by 2-dimensional sedimentation spectrum analysis (2-DSA) using the 
finite element modeling module provided in the Ultrascan software 
(http:/www.ultrascan.uthscsa.edu). Sedimentation profiles were analyzed at a grid resolution of 
25600 using 16 grid repetitions. Confidence levels were derived from 2-DSA data refinement 
using genetic algorithm followed by 50 Monte Carlo simulations. Calculations to analyze 
analytical ultracentrifugation data were performed on the UltraScan LIMS cluster at the 
Bioinformatics Core Facility at the University of Texas Health Science Center at San Antonio, 
the Lonestar cluster at the Texas Advanced Computing Center (supported by NSF Teragrid 
Grant #MCB070038 to Borries Demeler). vBar of 0.739 ml/g for ACP3 and ACP3-CD was 
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calculated from the polypeptide sequence and the buffer density (1.0235 g/ ml) and viscosity 
(1.2116 cp) were calculated using the buffer calculation module provided with the Ultrascan 
software suite.  
 
Dilution experiments by Isothermal titration calorimetry 
Dialyzed proteins prepared from gel filtration fraction were concentrated to the stability limits of 
the protein.  Using a MicroCal ITC, 300 µL of sample were loaded into the syringe and 1.7 mL 
of the dialysate was added to both the sample and control wells.  25 total injections, 5 µL for first 
injections and 10 µL for the remainder, were made into the sample cell held at 25°, with a 
spacing of 150 seconds and a stir speed of 310 rpm.  Data were processed using the Origin 7 
software suite according to the manufacturers guidelines and fit to the dilution function. 
 
Mass spectrometric analysis of proteins by LC-ESI-QTOF-MS 
The identities of the proteins in this study as well as the extent of phosphopantetheinylation of 
ACPs were determined by electrospray-time-of-flight mass spectrometry.  Protein samples were 
removed from the concentrated fraction prior to buffer exchange (minimum 2 mg/ml), diluted 
1:10, acidified with 10% (v/v) formic acid (FA), centrifuged at 20800xg for 10 minutes and 
transferred to a fresh tube.  Of this sample, 20uL was injected onto a C4 column (Phenomonex 
Aeris™ 3.6 µm WIDEPORE C4 300 Å, LC Column 50 x 2.1 mm) equilibrated with 30% 
CH3CN+0.1%FA, connected online with an Agilent 6250 quadrupole – Time-of-Flight mass 
spectrometer.  Column elution was diverted to waste for sample desalting for 1 minutes prior to a 
gradient of 30-95% CH3CN+0.1%FA over 8 minutes, followed by a 1 minute wash at 95% 
CH3CN+0.1%FA and reequilibration at 30% CH3CN+0.1%FA for 2 minutes.  For MS 
experiments requiring separation of halogenated and nonhalogenated ACPs, elution form a C8 
column (Agilent Zorbax 300SB 3.5µm, 50 x 4.6 mm) equilibrated with 30% 
CH3CN+0.1%FA+0.01% TFA was diverted to waste for sample desalting for 1 minutes prior to 
a gradient of 30-60% CH3CN+0.1% FA+ 0.01% TFA over 35 minutes, followed by a 5 minute 
wash at 95% CH3CN+0.1% FA+ 0.01% TFA and reequilibration at 30% 
CH3CN+0.1%FA+0.01%TFA for10 minutes.   
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All spectra were processed using the Bioconfirm Intact Protein module on the Agilent 
MassHunter Qualitative Analysis software.  Protein identities were confirmed by obtaining an 
averaged mass spectrum over maximum peak height as determined by Total Ion Chromatogram 
(TIC) with a 30second background spectrum subtracted.  Spectral deconvolution was performed 
over a range of 600-3000 m/z, using a minimum of 5 consecutive charge states and fit score of 7, 
with a limited mass range of ±15% of the calculated mass of the protein. 
 
Preparation of HMG-loaded ACP 
Apo- carrier proteins, as determined by mass spectrometry, were loaded with racemic 3-hydroxy-
3-methylglutaryl Coenzyme A (HMG-CoA). In a 1000 µL reaction (50 mM Tris (pH= 8.0) 50 
mM NaCl, 1 mM MgCl2, 10% (v/v) glycerol, 1 mM TCEP)), 150-300 µM ACP was incubated 
along with 5 µM recombinant Bacillus subtilis phosphopantetheinyl transferase, Sfp.  The 
reaction was initiated with the addition of freshly prepared HMG-CoA prepared as a 5 mM stock 
in MilliQ H2O.  5, 7.5 and 10 molar equivalents of HMG-CoA were used to ensure complete 
loading for single excised ACPs, ACP didomain and ACP tridomain constructs, respectively.  
Reactions were incubated at room temperature for 2 hours followed by dilution to 1.5mL with 
Buffer F.  The diluted reaction was loaded onto a HiTrap Desalting column (GE Healthcare) 
equilibrated with Buffer F and eluted with 2mL Buffer F, to remove unreacted HMG-CoA, 
TCEP and salts.  Proteins were concentrated, aliquoted, flash frozen in liquid nitrogen and stored 
at -80°.  The concentration was measured and extent of substrate loading was determined by 
mass spectrometry as above. 
 
BODIPY Labeling of apo-GCCT proteins 
Fluorophore bioconjugated ACPs were prepared from apo- carrier proteins harboring engineered 
cysteines, introduced by site directed mutagenesis and labeled with thiol reactive BODIPY N-
(4,4-Difluoro-5,7-Dimethyl-4-Bora-3a,4a-Diaza-s-Indacene-3-yl)Methyl)Iodoacetamide) 
(Invitrogen). Briefly, in a 1000 µL reaction, 50-75 µM ACP was incubated in Buffer F with 5 
equivalents of TCEP at room temperature for 10 minutes. BODIPY-Fl-C1-IA was prepared fresh 
in DMSO as a 10mM stock and added dropwise to the reaction in 5-10 molar excess of the ACP.  
The reaction was allowed to proceed in the dark at room temperature for 2 hours.  The reaction 
was quenched with 100 equivalents of β-mercaptoethanol followed by dilution to 1.5 mL with 
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buffer F.  The diluted reaction was loaded onto a HiTrap Desalting column (GE Healthcare) 
equilibrated with Buffer F and eluted with 2 mL Buffer F, to remove unreacted BODIPY, TCEP 
and β-mercaptoethanol.  Proteins were concentrated, aliquoted, flash frozen in liquid nitrogen 
and stored at -80°.  The concentration was measured and extent of labeling was determined by 
BCA assay and mass spectrometry as above. 
  
Halogenase activity assay 
Enzymatic assays were performed in order to analyze the activity of each of the β-branching 
proteins successively.  For each enzyme a 220 µL reaction (final volume), 50 mM Tris (pH= 
8.0), 50 mM NaCl, 10% glycerol, 1mM α-ketoglutaric acid (pH= 8.0) and freshly prepared 100 
µM (NH4)2Fe(SO4)2 were mixed.  5 µM halogenase was added to the reaction mixture and 
allowed to incubate at room temperature for 5 minutes.  Assays were initiated with the addition 
of HMG-ACP, prepared as above.  25 µL reactions aliquots were removed at specific time points 
and quenched with 10% formic acid.  Reactions were stored at -80° until processed.  All 
reactions were performed in triplicate.   
 
Quenched reactions were loaded onto a Pierce micro spin column packed with 40 µg C4 resin 
(ANALTECH) equilibrated with MilliQ H2O+0.1% FA and dried.  Samples were washed twice 
with 120 µL MilliQ H2O+0.1% FA, and eluted with 50µL 100% CH3CN+0.1% FA.  Reactions 
were analyzed by mass spectrometry as above. 
 
Relative activities of individual β-branching enzymes were quantified by comparing the 
abundances of the deconvoluted ACP masses corresponding to all transformation under 
investigation. 
 
Dehydratase, Decarboxylase and Cyclization reaction monitoring. 
Reactions of the ECH1, ECH2WT, ECH2dd and ER, were prepared as described for the 
Halogenase assay.  Assays were allowed to incubate at room temperature for 30-45 minutes in 
order generate the maximum amount of the requisite ACP bound substrate.  5 µM of respective 
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enzymes were added and 25 µL reactions aliquots were removed at specific time points and 
quenched with 10% formic acid.  Reactions were processed as above. 
 
One-pot assay for cyclopropane formation 
Assay mixtures were prepared as described for the Halogenase activity monitoring along with 
the Halogenase, ECH1, ECH2WT, and ER.  The reactions were allowed to incubate at room 
temperature for 10 minutes prior to the addition of the HMG-ACP.  Time points were removed, 
worked up and analyzed as described above.   
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Activated-elimination as a strategy for hydrocarbon production 
3.1 Introduction 
The adoption of biofuels as a renewable energy alternative has been slow as a consequence of the 
high cost and low processing efficiency of current methods in the acquisition of high-value, fuel-
like molecules.  Additionally, the absence of an infrastructure to support large-scale 
implementation of biomass-derived alternatives has led to a protracted shift in the energy 
paradigm.  This has led to a renewed impetus for the identification of drop-in replacements for 
fossil fuel and fostered the development of second-generation biofuels.  These novel surrogates 
are capable of being attained from non-food related feedstocks as well as microbiological 
sources. In order to address the growing need for a sustainable energy future, we have begun to 
harness the potential of a simple enzyme system from the marine cyanobacterium Lyngbya 
majuscula, demonstrating the capacity to produce molecules chemically identical to fossil fuels 
in vitro, working towards the establishment of a novel advanced biofuels platform. 
 
Our previous investigation of the curacin A bioassembly revealed a unique mechanism by which 
the natural product is released as the terminal alkene (Figure 35) (36).   Briefly, malonyl-CoA is 
activated by the CurM acyl transferase (AT) domain and transthioesterified to the CurM acyl 
carrier protein (ACP).  The CurM ketosynthase (KS) transfers the biosynthetic intermediate from 
the preceding module, decarboxylates the ACP bound malonate and catalyzes a Claisen-like 
condensation extending the growing chain by an acetate unit The β-keto group is then reduced to 
the alcohol with (R) stereochemistry by the keto reductase (KR) domain.  The sulfotransferase 
(ST) installs a sulfonate moiety on a newly formed β-hydroxy group, which is followed by 
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decarboxylation catalyzed by the thioesterase (TE) domain, yielding a terminal olefin. The 
tandem sulfonation-decarboxylation activity of this enzyme pair has been successfully 
reconstituted in vitro and characterized using a hydrocarbon-like substrate mimic (Figure 35).  
The focus of the ensuing research seeks to expand on these preliminary findings to harness the 
potential of cyanobacterial enzymes for the direct production of liquid fuel in vivo.     
 
3.2 Results 
3.2.1 Sulfotransferase-Thioesterase containing genes from additional cyanobacteria  
As an extension of our previous work (36) elucidating the desulfonative-decarboxylation 
mechanism leading to α-olefin formation in curacin A (Cur-) biosynthesis we identified three 
additional cyanobacterial genes containing the unusual termination sulfotransferase-thioesterase 
(ST-TE) didomain cassette suggesting that these modules catalyzed a similar offloading of 





























Figure 35.  Offloading of curacin A desulfonative-decarboxylation.  R1- wild type curacin A.  R2- substrate analog used to 




Unlike CurM, which is a component of a larger protein assembly line, these new ST-TE 
containing pathways appeared as stand-alone modules within the cyanobacterial genomes.  The 
overall sequence homology of the four proteins is 51.1%. 
 
The in vivo activity of the ST-TE gene from the Synechococcus PCC 7002 was recently 
characterized by Mendez-Perez and coworkers (59).   Through gene deletion studies, the Syn 
olefin synthase (Ols) was demonstrated to produce 1-nonadecene.  The odd-numbered, long-
chain alkene is presumed to arise from loading of octadecanoic acid directly on the Syn ACP1 by 
the acyl activating enzyme, followed by CurM like elongation, reduction and activated-
elimination catalyzed by the ST-TE didomain.  Motivated by the unique functionality of the Cur 
and Syn sulfotransferase and thioesterase enzyme pair in producing long chain hydrocarbons, we 
sought to assess the activities of the homologous domains from the Syn pathway to produce 
terminally olefinated products in vitro. 
 
3.2.1 SynTE is capable of accepting Cur substrate but does not yield alkene  
Our initial efforts were focused on the Synechococcus PCC 7002 (Syn) thioesterase (TE) and the 
ability of the protein to catalyze alkene formation.  A synthetic construct of the Syn ACP-ST-TE 
portion of the gene, codon optimized for protein expression in E. coli, was obtained and 
individual domains were cloned as excised proteins and overexpressed according to standard 
biochemical practices.   
 
Previously, detection of the alkene was carried out by thermal-desorption-GC-MS, however 





Figure 36.  Standalone cyanobacterial pathways identified to contain CurM-like ST-TE domains.
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ability to detect low abundance material, a rapid reaction workup and extraction protocol for GC-
MS was developed.  As positive controls for method validation, reaction-product-like molecules 
such as octane, decane, methyl 4-methyl-3-oxo valerate, 3-octynol-1-ol and decanal were 
prepared in reaction buffer at concentrations corresponding with <1% conversion of the ACP 
loaded substrate to alkene.  The samples were treated under standard reactions conditions, 
extracted, resuspended in a fixed volume, and analyzed by GC-MS (Figure 37).    
 
 
 The hydrocarbons were easily separable by GC and gave very abundant signal at concentration 
below 1000 pg/µL by EI-MS, validating both chromatographic and detection methods.  
Confident in our experimental design for hydrocarbon detection, we proceeded to analyze the 
ability of the SynTE to accept nonnative substrates and generate olefinated product. 
 
For a standard reaction, 5-(R)-methoxy-3-(R)-hydroxy-tetradecanoyl-ACP was prepared by 
incubating apo-carrier protein with the corresponding substrate-CoA and a phosphopantetheinyl 
transferase from Streptomyces versicolor, Svp.  Loaded carrier protein was incubated with CurM 
ST in order to generate the necessary 5-(R)-methoxy-3-(R)-sulfo-tetradecanoyl-ACP substrate 
for the TE reactions (Figure 38).  
 















Figure 37.  Standards used for GC-MS method development for hydrocarbon detection.
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The assay was initiated following the addition of either CurTE or SynTE Figure.   The reactions 
were quenched, worked up by extraction and analyzed for alkene formation.  To our dismay, no 
hydrocarbon products were detected for either Cur or Syn TE (Figure 39). 
 
This inability to detect the expected alkene, led us to reexamine the aqueous portion of the 
reaction for the product of the hydrolysis side-reaction.  Proteins were removed from the 
remaining samples by precipitation and the soluble fractions were analyzed by LC-MS. Indeed, 
the β-sulfo acid ionized well (Figure 40), suggesting that alkene formation occurs at a 





Figure 38.  Schematic for sulfotransferase and thiosterase catalyzed reactions. 
 
























The inability to detect olefin product from either TE reaction prompted a deep investigation of 
the distinctive function of the Cur and Syn TEs by surveying the unique structure adopted by 
these decarboxylating thioesterases (60).  As with other TEs, the Cur enzyme adopt a core α/β 
hydrolase fold, however significant deviations in quaternary structure from others in this class of 
protein, provide evidence to account for the uncommon function.  
Figure 40.  LC-MS analysis of the product of CurST and SynTE.  A. UV chromatogram.  Black trace- 210 nm.  Pink trace- 
230 nm.  B.  Total ion chromatogram.  Black trace- positive ion mode.  Pink trace- negative mode.  Inset- Selected ion 




The unusual core-to-lid dimerization interface of the TE exposes the Ser100-His266-Glu124 
catalytic triad, which may promote hydrolytic release, rather than alkene formation (Figure 41).  
Interestingly, Arg205, an invariant residue in the decarboxylating TEs, is conspicuously present 
above the active site, likely acting to stabilize interactions with the β-sulfate (60, 61).  This result 
was confirmed whereupon mutant TEs R205Q, R205E, and R205A demonstrated an almost 
complete loss of conversion of the sulfated substrates; however reactivity towards the β-hydroxy 
substrates remains unchanged.   
 
3.2.2 SynTE HRSC double mutant prepared for active site labeling protein 
To elucidate the origins of the3unexpected product discrimination, a SynTE double mutant 
(SynTE HRSC) was generated, replacing two of the highly conserved catalytic triad Ser-His-Glu 
residues, S100C and H263R.  Identical mutations have previously been utilized for active site 
A- Tmc TE






Figure 41.  Structural comparison of hydrolysing and decarboxylating thioesterases  A.  Tautomycetin TE.  B.  Curacin TE.
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labeling studies characterizing the TE domain from the Streptomyces derived 







































































































































































































































































































































































The activity of the thioesterase was determined by incubating CurM ACP loaded with 3-(R)-OH-
tetradecanoyl-CoA, CurM ST and either wild type or mutant SynTE and determining a mass 
balance for the reaction with the hope of capturing substrate in the active site of the TE as a 
means of determining amino acids implicated in the hydrolysis-alkene formation equilibrium.  
While the activity of the SynTE HRSC was slightly reduced relative to wild type, as determined 
by the decreased conversion of the loaded CurM ACP to the holo- form of the protein, no active 
site labeling was observed using top-down mass spectrometric analysis (Figure 42).   
 
This is likely attributable to the earlier described differences in exposure of the active sites of the 
TmcTE as contrasted with the SynTE.  A feature common to TEs catalyzing hydrolysis is a 
solvent occluded substrate pocket.  However differences in the crystal structures of the Tmc TE 
and Cur TE clearly demonstrate a novel, solvent exposed active site, with coordination of the 
sulfate group via positively charged Arg205.    
 
3.2.3 Alternative methods of olefin detection via alkene functionalization  
To further characterize olefin production capacity and investigate substrate flexibility of ST-TE 
containing genes alternative methods of detection of the alkene were explored.  Typically, alkyl 
chains are well suited for measurement by GC-EI-MS, however, as a result of the large 
percentage of conversion of ACP bound substrate that undergoes the unproductive hydrolysis 
reaction, rather than alkene formation, direct observation of the low abundance olefin product 
has been challenging.  Additionally, the insolubility of the long chain hydrocarbon under the 
enzymatic conditions, likely promotes volatilization over the course of the reaction and workup.  
Taken together his prompted us to look at the use of alkene-enrichment techniques.   
 
Thiol-ene coupling presented itself as a reaction workup method, which would allow for the 
simultaneous detection and quantification of the sulfo-acid hydrolysis as well as alkene product 
by LC-MS.  Initially pioneered as a solvent-free alternative to thiol-conjugation, thiol-ene 
chemistry takes advantage of UV stimulated radical formation, mediated through a radical 
initiator, and leads to the anti-Markovnikov addition of a thiol across a double bond (62-64). 
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Experiments coupling a 1-tridecene standard and the N-acetylcysteamine were successful under 
typical reaction conditions, including 10% methanol as a solubilizing agent for the radical 
initiator, benzophenone, generating a product that is amenable to detection by LC-MS (Figure 
43).  Unfortunately, when the reaction was run, UV exposure caused proteins to rapidly 
precipitate and no derivatized alkene was detected.   
 
 
3.2.4 Syn and Cur proteins act functionally in trans and accept nonnative substrates 
The ultimate and penultimate domains from the final module in the curacin biosynthetic pathway 
constitute a dienzyme cassette that represents a novel PKS offloading mechanism. In our 
previous investigation into this unusual enzyme pair, we utilized an analog of the terminal 
curacin chain elongation intermediate, 5-(R)-methoxy-3-(R)-hydroxy-tetradecanoyl-CoA, which 
was loaded onto CurM ACP as substrate.  This flexibility suggests the enzymes possess 
reactivity toward related acyl chain analogues containing a β-hydroxy.  In order to further probe 
the promiscuity of the protein pair towards nonnative substrates, and evaluate the production 
capacity of the CurM enzymes to generate fuel-like hydrocarbons directly, we examined the 
ability of the sulfotransferase to accept further simplified acyl-substrates.   
 
Figure 43.  Thioclick enrichment of alkene containing compounds.  A.  Scheme for thiol-ene coupling of 1-tridecene and N-
acetylcysteamine using benzophenone radical initiator.  B.  Average mass spectrum of product of thioclick reaction.  Expected 
[M+H]- 302.24.  Observed- 302.29.
 56 
Synthetic substrates lacking the 5-methoxy group were designed and synthesized in collaboration 
with the Wipf group at the University of Pittsburgh. 3-(R)-hydroxy-tetradecanoyl-CoA was 
prepared using a similar route to as described previously (36).  Substrates were loaded onto apo-
CurM ACP using the phosphopantetheinyl transferase, Svp (65).   The loaded carrier protein was 
incubated along with the sulfate donor, 3'-phosphoadenosine-5'-phosphosulfate (PAPS), as well 
as CurST, CurTE or both enzymes and the reactions monitored by LC-MS.  Incubation of CurM 
ACP alone as a negative control revealed a micture of loaded- and holo- carrier protein and gave 
a baseline for the downstream analysis (Figure 44).  Addition of the CurTE to the reaction 
mixture resulted in no change (data not shown).  Incubation of the loaded ACP and CurST 
resulted in the formation of a new peak with an 80Da mass shift, in agreement with the β-
sulfonation (Figure 45).  A mixed population of the holo-, loaded-, and sulfo- species as 
discerneable,  suggesting the ST catalyzed transformation did not go to completion.  By HPLC, 
the ST-TE containing reactions demonstrate a marked shift in the retention time of the carrier 
product (Figure 46), indication that the enzymes are functioning in tandem, though in agreement 




Figure 44.  LC-MS analysis of the product of CurM ACP loaded with 3-hydroxy-tetradecanoyl-CoA.  A. Zoomed UV 
chromatogram; black trace 220nm, pink trace 280nm; inset full chromatogram.  B.  Average mass spectrum of protein peak 
denoted by asterisks.  C.  Charge state assignment for Svp and ACP isoforms.
 58 
Figure 45.  LC-MS analysis of the product of CurST and CurM ACP loaded with 3-hydroxy-tetradecanoyl-CoA.  A. Zoomed 
UV chromatogram; black trace 220nm, pink trace  280nm; inset full chromatogram.  B.  Average mass spectrum of protein 
peak denoted by asterisks.  C.  Charge state assignment for Svp and ACP isoforms.
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Figure 46 LC-MS analysis of the product of CurST, CurTE CurM ACP loaded with 3-hydroxy-tetradecanoyl-CoA.  A. 
Zoomed UV chromatogram; black trace 220nm, pink trace 280nm; inset full chromatogram.  B.  Average mass spectrum of 
protein peak denoted by asterisks.  C.  Charge state assignment for Svp and ACP isoforms.
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Having demonstrated the ability of the CurST domain to sulfonate the β-alcohol of nonnative-
acyl chains, we sought to probe the capacity of the domains from the Syn and Cur system to act 
in trans. Remarkably, both CurST and SynST were capable of interacting with non-cognate 
ACPs (Figure 47), however the Syn sulfotransferase demonstrated approximately 20% activity as 
compared with Cur enzyme.  Interestingly, while the SynST was capable of interacting with the 
Cur proteins, the enzyme was incapable of accepting the CurM-substrate harboring the 5-
methoxy for sulfonation as determined by HPLC (66). 
     
3.2.5 ST structure and loop exchange 
In order to understand the observed substrate intolerances, and gain access to more fuel-like 
molecules through the functioning of ST-TE enzyme pair, we undertook a structural 
investigation of both the Cur and Syn STs (66).  These enzymes represent a novel subclass of 
sulfonating proteins that possess a unique fold, surface substrate binding cleft, as well as a 
dynamic active site flap.  Mechanistically, the CurST and SynST also share a common 3'-
phosphoadenosine-5'-phosphosulfate binding mode that was reveled through electron density at 
Figure 47. LC-MS analysis of the product of SynST and CurM ACP loaded with 3-hydroxy-tetradecanoyl-CoA.  A. Zoomed 
UV chromatogram; black trace 220nm, pink trace 280nm; inset full chromatogram.  B.  Average mass spectrum of protein 
peak denoted by asterisks.  C.  Charge state assignment for Svp and ACP isoforms.
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the active site with ZnCl3, as the PAPS SO4 surrogate.  The major distinguishing element 
between the proteins was the active site flap, which remained unstructured in the SynST crystal 
though ordered for CurMST.  The role of this 13 amino acid region in substrate recognitions was 
determined by generating chimeric forms of each enzyme, by exchanging the respective flap 
regions.  For the CurMSTflapSyn, the activity towards the β-hydroxy substrates remained 
unchanged, while the ability to accept methoxy-bearing substrates was reduced by 50%.   The 
SynSTflapCurM showed a near complete loss of activity for the β-hydroxy substrates, however, 
remarkably, the enzyme was now tolerant the CurM 5-(R)-methoxy-3-(R)-hydroxy-
tetradecanoyl-ACP substrate.  Taken together these results demonstrated the ability of the 
sulfotransferase to selectively accept substrate is partially conferred through the active site flap.   
 
3.2.6 Chemical and enzymatic access of acyl-CoA substrates 
Seeking to further expand our substrate pool for examining ST and TE activities, alternative 
methods for generating acyl-CoAs were examined.  Synthetic preparation of substrates for this 
study, first utilized methods developed by Walsh and coworkers, wherein acyl-acids are ligated 
to CoA, N-acetylcysteamine or phosphopantetheine or other chemical ACP surrogates using 
PyBOP as the coupling agent, di-isopropylethylamine (DIPEA) as the base and an excess of thiol 
ranging from 2-10 molar equivalents (67). Recent studies using full-length chain elongation 
intermediates prepared as thiophenol thioesters, demonstrate chain transfer of substrate by 
processing domains and conversion by downstream PKS and NRPS enzymes; this study 
suggested the ability to overcome the need for CoA loading onto ACPs for downstream ST-TE 
reaction.  Alternatively, Padamakumar et al. (68) have prepared malonyl-thiophenolates for a 
direct transthioesterification onto CoA.  Though thiophenolate adducts are obtainable for 3-OH 
fatty acids ranging from 8-12 carbons, the amphipathic longer chain substrates makes the second 
step of the reaction implicitly more challenging.  This is consistent with yields decreasing from 
90-60% between C-12 to C14 carbons chain lengths.  Moreover, 0% conversion is observed for 
C16-18 carbon chains. 
 
The inability to chemically prepare longer chain acyl-CoA substrates, prompted us to investigate 
the enzymatic preparation of acyl-CoAs.  The mycobacterial acyl-CoA ligase, FadD6, was 
previously shown to activate free fatty acids directly as CoA thioesters in an ATP dependent 
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reaction (69, 70).  Several constructs of the mycobacterial FadD6 were graciously donated by RS 
Gokhale.  As the role of this enzyme during the research was preparative, we screened each form 
of the enzyme for ease of overexpression, purification and highest activity.  The MBP-FadD6 
proved to give the highest yield and was chosen for downstream application.  Fatty acids of 
varying length were incubated with FadD6.  Reactions were quenched removed of insoluble 
material and analyzed by HPLC.  While FadD6 demonstrated a substrate profile similar to what 
was previously reported (69, 70), capable of accepting fatty acid ranging in chain length and 
oxidation at the C-3 position, the enzyme showed significantly lower turnover for C14-C18 fatty 
acids.  Additionally, functionalization of the longer chain acids with a β-alcohol resulted in an 
even lower turnover.  The high cost of non-recoverable starting material from this reaction and 
large scale required to access minute amounts of β-hydroxy acyl CoAs and instability during 
purification led us to abandon this method. 
 
 
Figure 48. LC-MS analysis of FadD6 catalyzed formation of 3-OH-tetradecanoyl-CoA.  A.  Total ion chromatogram.  Asterisk 
denotes unreacted CoA.  B.  Extracted ion chromatogram.  Red trace and orange trace, selected ion monitoring for CoA in 
positive and negative mode.   Yellow and green trace selected ion monitoring of 3-OH-tetradecanoyl-CoA in positive and 
negative mode.  C.  Mass spectral average for CoA in positive mode.  D.  Mass spectral average for CoA in negative mode. E.  
Mass spectral average for 3-OH-tetradecanoyl-CoA in positive mode.  F.  Mass spectral average for 3-OH-tetradecanoyl-CoA 
in negative mode.  
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3.2.6.1 Acyl activating enzymes couple free fatty acids to holo-carrier proteins  
Throughout this study, CoA substrates were loaded using Svp onto apo- carrier protein in an in 
vitro biochemical surrogacy.  The high cost and synthetic or enzymatic difficulties encountered 
while producing these activated thioesters, led us to consider utilizing enzymes in the direct 
acylation of holo- carrier proteins with a nonactivated (i.e. free acid) substrate, bypassing the 
need for substrate derivitization and the need for a loading step. 
 
An examination of the related cyanobacterial ST-TE containing gene clusters, revealed a protein 
not found within CurM, annotated to be an acyl activating enzyme (AAE).  BLAST analysis 
indicated that this protein belonged to the fatty acyl-AMP ligase (FAAL) superfamily, which 
utilizes ATP to catalyze the formation acyl-adenylates. Enzymatically, this class of proteins 
share incredibly high similarity to the related fatty acyl-CoA ligase (FACL), which like FAALs 
form, acyl-AMP intermediates, but follow this by a second round of catalysis transferring the 
substrate to the terminal thiol of CoA, or to a holo-carrier protein.  This class of enzymes is 
found in principally in secondary metabolism, having been recently characterized in phthiocerol 
dimycocerosate (71) and  mycolic acid (72) biosynthesis.   
 
A global alignment of several FAAL as well as FACLs, show modest sequence homology 
(~20.2%), with a highly conserved nucleotide-binding motif.  Interestingly, the Synechococcus 
PCC 7002 acyl activating enzyme possess the distinguishing insertional region between the N-
and C- terminal subdomains (Figure 49) (73), clading the protein firmly within the FAAL 
subclass of Adenylate-forming-domain proteins.  This finding would suggest that the protein 





Figure 49.  Alignment of fatty acyl CoA ligases and fatty acyl AMP ligases.   The common interdomain insertion 
distinguishing FACLs from FAALs, denoted by a blue bar, is also present in the Syn acyl activating enzyme.  
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The AAE was cloned from genomic Synechococcus PCC7002 DNA as an excised domain, 
purified to homogeneity and the identity of the protein was confirmed by mass spectrometry.  To 
test the activity of the enzyme, AAE was incubated with ATP, Mg2+, stearic acid, and holo-CurM 
ACP and modifications to the ACP were monitored by MS.  To our surprise, under all conditions 
tested, no modifications to the CurM ACP were detected. 
 
 
Analysis of the literature regarding secondary metabolic activating enzymes indicated that a 
common attribute of FACLs is the ability of the protein to discriminate amongst cognate ACPs 
(72, 74, 75).  This feature enables interactions to occur at precise timing during the biosynthesis 
of secondary metabolites, raising the potential that the AAE would specifically load the native 
downstream ACP.  Alignment of the CurM ACP as well as the 2 Syn ACPs demonstrates the 
dissimilarity of the proximal carrier protein to the distal carrier proteins and its potential 
involvement in the AAE specific interaction (Figure 51).   
 
Two constructs of the SynACP1 were cloned from genomic DNA and were designed to include 
the minimally conserved ACP domain, DQH construct, or include a long N-terminal region that 






Figure 50.  Reaction scheme for examining AAE activity.  Conversion of holo-ACP to fatty acid loaded carrier protein was 
monitored by LC-MS.
Figure 51.  Alignment of ACPs from CurM and Syn olefin synthase.  Blue bar indicates highest conserved region and potential 
ACP recognition interface.  
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The ACPs were prepared in the holo-form and confirmed by MS.  The AAE and SynACP1 
constructs were incubated along with stearic acid and reaction cofactors as previously described, 
and monitored by MS.  For the shorter DQH construct, no modifications to the ACP were 
observed, however, analysis of the total ion chromatogram (TIC) showed a new peak with 
slightly increased retention time, appearing upon incubation of AAE and LDG-ACP (Figure 52). 
 
Deconvolution of the mass spectrum revealed a new peak with a mass increase of 267 Da, 
relative to WT, in agreement with the addition of stearic acid (Figure 53).   




Localization of the mass increase was determined to be at the PPant prosthetic group on the ACP 
by comparison of the PPant ejection ion (PPEI) products of the negative control lacking the 
AAE, and reactions containing the enzyme (Figure 54).  
Figure 53. Deconvoluted mass abundances for AAE loaded SynLDG-ACP .  Indicated with a single asterisk is the holo- 




To maximize ACP loading, reaction conditions were scouted to increase the availability of the 
substrate by dissolving the free fatty acid in a variety of protein amenable cosolvents such as 
methanol, ethanol, and DMSO.  Though the AAE is an incredibly well behaved protein in 
solution, it also appeared to be the least stable component of the reaction mixture with 
precipitation occurring under all conditions tested.   
 
3.3 Discussion 
The unique alkene forming off-loading mechanism, first characterized in the Curacin pathway 
represents a novel method for the biosynthetic production of terminally olefinated small 
molecules.  Domains from the related pathway from Synechococcus PCC 7002, were 
demonstrated to have similar activity, though less tolerant to substrate functionalization than the 
corresponding Cur proteins.  The full length Synechococcus Ols protein was recently 
overexpressed in E. coli (76) though no alkene production was reported.  This result is in-line 
with the undetectable levels of hydrocarbon generated from the excised domains under in vitro 

















Figure 54.  Zoom of average mass spectrum from 3.330-3.586 min for AAE loaded SynLDG-ACP.   Indicated with a single 
asterisk is the holo- PPEI,Calc- 261.12, Obs- 261.2; two asterisks denotes stearate loading, Calc- 527.3, Obs- 527.3.
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concentration than the TE domain.  It is possible that the equilibrium for the second half of the 
TE functionality is strongly perturbed by the excess of substrate and that by limiting the amount 
of β-sulfo-acyl-ACP, higher titers of the alkene can be generated. Examining the activity of 
single turnover reactions using an ACP-ST-TE tridomain may demonstrate the 1:1 ratio of ACP 
to TE is critical for hydrocarbon production. If this mode is demonstrated to be successful in 
alkenes formation, the single turnover nature of the tridomain can be overcome by replacing the 
carrier protein with an ACP capable of being loaded by an acyl activating enzyme, thus 
generating a platform for the direct conversion of free fatty acids to alkene hydrocarbons. 
 
As with other biofuel alternatives, critical barriers to the implementation of pioneering 
technologies are overcoming potential socio-political challenges.  The discourse surrounding 
bioenergy alternatives continues to largely oppose the supplantation of fossil fuels. This 
resistance comes from the gas and petroleum industries in addition to domestic and foreign 
policy makers.  Of principal concern for the long-term adoption of biofuels are the translational 
costs of utilizing biomass for fermentation, the need to curb greenhouse gas production and the 
ability to keep pace with increasing international energy demands.  Global competition for arable 
land in either food production or as biofuel feedstocks has led to a rise in land costs along with 
the price of major agricultural commodities such as corn and soybeans. Within our developing 
biofuels system, this imbalance is overcome by virtue of the native biology of aquatic 
photoautotrophs from which the olefin synthase genes of interest originate.  Blue-green algae are 
readily cultivable on nonarable land and in non-potable water, thus ameliorating concerns over 
the appropriation of farmable land and limited water resources.  Additionally, the inherently 
higher photosynthetic-efficiency of cyanobacteria contrasted with terrestrial plants, leads to an 
increased capture of CO2 from the atmosphere, which has correlated directly with increased 
growth rates and higher hydrocarbon titer per gram of biomass.  A comparison study of the total 
usable energy output from microalgae has demonstrated a 2,000 – 16,700% greater oil 
production efficiency than traditionally derived biomass on a per hectare basis, firmly 
establishing cyanobacteria as valuable biofuel alternative.   
 
Unlike current alternatives to fossil fuels, major infrastructure and economic challenges are also 
mitigated using an algae-based biofuel platform.  The energy balance for ethanol derived from 
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corn is known to be net negative, primarily due to expenses associated with industrial production 
using corn feedstocks and the large energy input required for the separation and isolation of 
ethanol.  Furthermore, the lower energy density and high hygroscopicity of ethanol renders it 
unusable in current engine and distribution networks.  In contrast, the nature of the liquid fuel 
generated from our enzyme system make them directly compatible with the current fossil-fuel 
infrastructure as a drop-in alternative, thus obviating the need to construct a biofuels-compatible 
framework. 
 
3.4 Materials and methods 
Bacterial strains, media and culture conditions. 
Escherichia coli DH5α subcloning efficiency cells (Invitrogen) were used as axenic stocks for 
the preparation of electrocompetent cells for DNA propagation and maintenance.  Escherichia 
coli Rosetta BL21(DE3) (Novagen) harboring the pRARE plasmid (spectinomycin resistance 
exchanged for chloramphenicol by Dr. W. Clay Brown, University of Michigan) for general 
protein overexpression; holo- carrier proteins were obtained using the BAP1 cell line (Pfeifer). 
All transformations were achieved via electroporation (BioRad, Gene Pulser Xcell), with 2.5-500 
ng DNA from ligation reaction mixture or as intact plasmid, recovered with SOB, allowed to 
outgrow for 60 minutes prior to plating on lysogeny broth-Miller-agar plates (LB-Miller) 
supplemented with the appropriate antibiotic (ampicillin- 50 µg/mL, kanamycin- 50 µg/mL, 
spectinomycin- 25 µg/mL). 
 
Protein overexpression, media and culture conditions 
Fresh transformants harboring the plasmid of interest were used to inoculate a culture of 
lysogeny broth-Miller (LB-Miller), corresponding with plasmid resistance marker (ampicillin- 
50µg/mL, kanamycin- 50µg/mL, spectinomycin- 25 µg/mL).  Overnight (~12-18 hours) cultures 
were used to subinoculate (1:100 (v/v)) large-scale (500-1000 mL) cultures supplemented with 
appropriate antibiotics for protein overexpression.  Apo- carrier proteins were cultured in LB-
miller supplemented with 1% (v/v) Glycerol, 25mM Tris (pH= 7.5), and freshly prepared 100 
µM Fe(II)SO4, while the ST, TE AAE and SVP were cultured in LB without modification.   
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For all proteins of interests, large-scales cultures were grown at 37° while shaking at 160 RPM 
until reaching an OD600 0.6-0.8.   Flasks were allowed to cool at room temperature for 20-30 
minutes.  Protein overexpression was induced with the addition of isopropyl-β-D-
thiogalactopyranoside (IPTG) to a final concentration of 0.3-0.4 mM.  Flasks were returned to a 
20° shaker and continued to grow. Apo- carrier proteins were harvested following 5 hours 
induction, while ST, TE AAE and SVP were allowed to grow for 12-16 hours prior to 
harvesting.  Cells were harvested by centrifugation at (5000xg, 10 minutes, 4°), transferred to 50 




All steps during the protein purifications were performed at 4°.  Cell pellets were resuspended in 
2x cell volume (minimum 25mL) 5-10% Buffer B, and incubated with freshly prepared 
lysozyme (0.2 mg/mL final, prepared in MilliQ H2O), freshly prepared PMSF (1 mM final, 
prepared in DMSO) and 0.5 cOmplete protease inhibitor cocktail (Roche) tablet for 30 minutes 
while rocking.  Cells were lysed by use of a recently tuned ultrasonic dismembrator for 10 cycles 
of 1 minute, with pulses of 5 seconds on, followed by 5 seconds off, and intensities ranging from 
7-8.  All cycles were carried with chilled beakers in packed ice bucket.  Cellular debris was 
removed by centrifugation at 40000-50000xg for 30 minutes and the supernatant was transferred 
to a fresh tube; residual insoluble material was removed by filtration (syringe driven 0.45 µm 
filter) or a second round of centrifugation.   
 
Immobilized metal affinity chromatography  
Clarified lysate was applied to 2 mL nitrolotriacetic acid-agarose resin (Qiagen), charged with 
Ni2+, and equilibrated with 10-20% Buffer B.  The resin was washed extensively with 25 column 
volumes of 15-30% buffer B to remove any nonspecifically bound proteins.  The target protein 
was eluted with a stepwise gradient from 20-100% Buffer B.  Peak fractions as determined by 
gradient SDS-PAGE ((4-12%) (Novex NuPage) run in MES buffer at 180 mV for 50 minutes) 
were pooled and concentrated using Amicon ultra centrifugal concentrators (Millipore, 0.5 kDa, 
3 kDa, 10 kDa), equilibrated with Buffer F until a volume of 2.5 mL was reached.  Proteins were 
buffer exchanged with a PD10 washed and equilibrated with Buffer F and eluted with 3.5 mL of 
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Buffer F.  Proteins were further concentrated to less than 100-500 µL, aliquoted, flash frozen in 
liquid nitrogen and stored at -80°.  Protein concentrations were determined using the 
bicinchoninic acid assay (BCA Pierce) according to the manufacturers guidelines, using a BSA 
standard curve and read in 96 well format. 
 
Preparation of substrate-loaded ACP 
Apo- carrier proteins, as determined by mass spectrometry, were loaded with either (R) 3-
hydroxy-tetrdadecanoyl Coenzyme A, or (R) 5-methoxy-3-hydroxy-tetrdadecanoyl Coenzyme A. 
Briefly,  in a 1000 µL reaction (50 mM Tris (pH= 8.0) 50 mM NaCl, 1 mM MgCl2, 10% (v/v) 
glycerol, 1 mM TCEP)), 250-500 µM ACP was incubated along with 5 µM recombinant 
Streptomyces versicolor phosphopantetheinyl transferase, SVP.  The reaction was initiated with 
the addition of 10 molar equivalents of substrate-CoA prepared as a 5 mM stock in MilliQ H2O.  
Reactions were incubated at room temperature for 2 hours followed by dilution to 1.5mL with 
Buffer F.  The diluted reaction was loaded onto a HiTrap Desalting column (GE Healthcare) 
equilibrated with Buffer F and eluted with 2 mL Buffer F, to remove unreacted CoA, TCEP and 
salts.  Proteins were concentrated, aliquoted, flash frozen in liquid nitrogen and stored at -80°.  
The concentration was measured and extent of substrate loading was determined by mass 
spectrometry as above. 
 
Mass spectrometric analysis of proteins by LC-ESI-MS 
Excised domain, as well as coupled, Cur and Syn ST-TE reactions were carried out as described 
in Gehret et al. (60, 66). The 300 µL reaction was partitioned into 100 µL aliquots for analysis 
by HPLC, LC-MS, GC-MS (see below). AAE reactions were carried out in 50 µL volumes and 
processed similarly for exclusively LC-MS analysis.   
 
The identities of the proteins in this study as well as the extent of phosphopantetheinylation of 
ACPs except for sulfonation experiments (see below) were determined by electrospray-time-of-
flight (TOF) mass spectrometry.  Protein samples were removed from the concentrated fraction 
prior to buffer exchange (minimum 2 mg/ml), diluted 1:10, acidified with 10% (v/v) formic acid 
(FA), centrifuged at 20800xg for 10 minutes and transferred to a fresh tube.  Of this sample, 
20uL was injected onto a C4 column (Phenomonex Aeris™ 3.6 µm WIDEPORE C4 300 Å, LC 
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Column 50 x 2.1 mm) equilibrated with 30% CH3CN+0.1% FA, connected online with an 
Agilent 6250 quadrupole – Time-of-Flight mass spectrometer.  Column elution was diverted to 
waste for sample desalting for 1 minutes prior to a gradient of 30-95% CH3CN+0.1%FA over 8 
minutes, followed by a 1 minute wash at 95% CH3CN+0.1%FA and reequilibration at 30% 
CH3CN+0.1%FA for 2 minutes.  Alternatively a PLRP-S column (Varian 3 µm, LC Column 50 
x 4.6 mm) equilibrated with 10% CH3CN+0.1% FA was connected online with a Shimadzu LC-
MS 2010 EV (single quadrupole, ESI configuration operated in the positive, profile mode).  
Column elution was diverted to waste for sample desalting for 5 minutes prior to a gradient of 
10-95% CH3CN+0.1% FA over 20 minutes, followed by a 5 minute wash at 95% 
CH3CN+0.1%FA and reequilibration at 10% CH3CN+0.1%FA for 10 minutes. 
 
Spectra acquired using TOF were processed using the Bioconfirm Intact Protein module on the 
Agilent MassHunter Qualitative Analysis software.  Protein identities were confirmed by 
obtaining an averaged mass spectrum over maximum peak height as determined by Total Ion 
Chromatogram (TIC) with a 30 second background spectrum subtracted.  Spectral deconvolution 
was performed over a range of 200-2000 m/z, using a minimum of 7 consecutive charge states 
and fit score of 8, with a limited mass range of ±10% of the calculated mass of the protein.  
Experiments using the single quadrupole mass spectrometer were deconvoluted by hand using 
the calculated average mass mass-to-charge ratio for individual proteins as a reference for peak 
assignment. 
 
GC-EI-MS analysis of hydrocarbon production 
TE catalyzed olefinative offloading was determined using a protocol adapted from conversations 
with Dr. Liangcai Gu. The 100 µL reaction aliquots (see above) were diluted to 500 µL with 
MilliQ H2O and extracted thrice with an equal of ethyl acetate (EtOAC).  The samples were 
dried under nitrogen gas and subsequently reconstituted in 500 µL EtOAC.  GC-MS assays were 
conducted using a Shimadzu QP-2010 GC-MS single quadrupole mass spectrometer.  GC 
methods were developed using acyl-chain standards, systematically worked-up as with 
enzymatic reactions.  Maximal allowable injections of 8 µL (splitless) were made onto a DB-5 
column (Agilent, 30 m x 0.25 mm) operating with helium-carrier gas. The injector and detector 
temperatures were set at 200°C. After an initial setting at 30°C for 2 minutes, the oven 
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temperature was raised to 250°C at 18.3°C /min and held for 2 minutes.  Spectra covering a mass 
range of 50-500 m/z were collected and processed with the Labsolutions Postrun software.  
 
Thio-click derivatization of enzymatically produced olefins  
Alkene functionalization proceeded using experimental methods adapted protocols outlined in 
Hoyle et al. (64).  Briefly, in a 1000 µL reaction (50 mM Tris (pH= 8.0), 300 mM NaCl, 10% 
(v/v) MeOH) 60 µM 1-tridecene was mixed along with 600 µM N-acetylcysteamine and 0.6 µM 
benzophenone (prepared in MeOH).  The mixture was incubated at room temperature for 30 
minutes in a foil-lined box under exposure to a handheld UV-lamp.  The reaction was processed 
by centrifugation at 20800xg for 10 minutes to remove insoluble material and loaded onto a 1 
mL disposable reverse phase octadecyl extraction column (Bakerbond, C18) equilibrated with 
5%  (v/v) MeOH+ 0.1% FA.  The column was washed with 10 column volumes of 5%  (v/v) 
MeOH+ 0.1% FA and subsequently eluted with a stepwise gradient of 10%-100% MeOH+ 0.1% 
FA in 1 mL fractions.  20 µL samples of each fraction were assayed for thioclick-product loading 
sample onto an XBridge C18 column (Waters, 100 mm x 4.6 mm) equilibrated with 30% MeOH 
connected online with a Shimadzu LC-MS 2010 EV (ESI configuration).  Column elution was 
diverted to waste for sample desalting for 1 minutes prior to a gradient of 30-95% MeOH over 
10 minutes, followed by a 10 minute wash at 95% MeOH and reequilibration at 30% MeOH for 
10 minutes.  Profile spectra were acquired in the positive mode over a range of 50-500 m/z using 
and processed in Labsolutions Postrun software. 
  
 
FadD26 catalyzed acyl-CoA formation  
CoA ligation reactions were carried out as described in Arora et al. (70) without modification.  
The reactions were quenched with the addition of 10% (v/v) ice-cold trichloroacetic acid and 
centrifuged at 20800xg for 10 minutes to remove precipitated proteins.  10 µL of the soluble 
fraction was loaded onto an XBridge C18 column (Waters, 100 mm x 4.6 mm) equilibrated with 
10% CH3CN (in 10 mM CH3COONH4 (pH= 5.4)) connected online with a Shimadzu LC-MS 
2010 EV (ESI configuration).  Column elution was diverted to waste for sample desalting for 5 
minutes prior to a gradient of 10-95% CH3CN over 20 minutes, followed by a 5 minute wash at 
95% CH3CN and reequilibration at 10% CH3CN for 10 minutes.  Spectra were acquired in both 
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the positive and negative mode over a range of 100-2000 m/z and processed in Labsolutions 
Postrun software. 
 
AAE loading of holo- carrier proteins 
Acyl activating enzyme loading was examined via a protocol similar to the characterization of 
ligases by Zhang et al.(73).  Briefly in a 50 µL reaction  (50 mM Tris (pH= 8.0) 50 mM NaCl, 1 
mM MgCl2, 1% (v/v) glycerol, 10 mM ATP, 10% (v/v) MeOH), 50 µM ACP was incubated 
along with 500 µM stearic acid (prepared in MeOH) and 0.5-5 µM AAE.  The reactions were 
monitored for turbidity associated with protein precipitation during incubation at 24°C, and 
quenched with formic acid (10% (v/v) final concentration) at times associated with a loss 
turbidity increase.  Quenched reactions were analyzed by LC-MS as described above.       
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Origins of the linear lipopeptide carmabin A 
4.1 Introduction 
Marine cyanobacteria have been well noted for the incredible structural diversity and broad 
biological activities of small molecules produced within the cyanobacterial secondary 
metabolome (21, 77, 78).  A common scaffold of these metabolites includes an acyl chain linked 
to a polypeptide, suggesting that the majority of these compounds are of mixed polyketide 
synthase (PKS) and nonribosomal peptide synthethases (NRPS) origin.  Structural elaboration is 
achieved amongst this class of natural products by varying the chain length and level of 
unsaturation of the fatty acyl tail, as well as through the incorporation of the nonproteinogenic 
amino acids and β-hydroxy acid monomers, leading to depsipeptide bonds within the mature 
compound (11).  Further diversity is obtained during the termination process wherein the small 
molecule can be either cyclized or offloaded as a linear small molecule.  Interestingly, unlike 
canonical cyclization strategies for macrolactone biosynthesis, such as pikromycin or 
erythromycin, the fatty acid chain remains unincorporated into the ring system. 
 
Within the family of linear cyanobacterial metabolites, carmabin A, structurally characterized 
initially in 1998 (28) and recently coisolated with the structurally homologous dragomabins and 
dragaonamides (79), represent a class of lipopeptides with antimalarial activity (Figure 55).   
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The core scaffolds share an alkyne, attached via a C8-C10 acyl linker, to a tetrapeptide with a 
highly N-methylated backbone terminating in a previously unobserved amide.  In addition to this 
small family of related molecules, the previously identified jamaicamides(27) also possess an 
alkyne.  Given the presence of this functionality, it was thought that this chemical group would 
be critical to the bioactivity of the small molecule.  This hypothesis allowed McPhail et al. (79) 
to glean some relationship between the structure of the metabolite and antimalarial activity.  
Each of the compounds were assayed for antiplasmodial activity against a known chloroquinone-
resistant strain of malaria.  While all four lipopeptides possessed the acetylene group, only the 
aromatic containing carmabin A, dragomabin and dragonamide A were efficacious with IC50 
values of 1.4, 21.0 an 10.7 µM, respectively.  Interestingly the activity of jamaicamide B, which 
has no aromatic rings, was similar to the other metabolites, 18.4 µM, while no activity was 
observed for terminal bromo-acetylene containing jamaicamide A.  Together this suggested that 
critical interactions between the natural product and target are being enabled via the alkyne.  
Moreover, the aromatic residues and pyrrolinone functionality of jamaicamide A, play an 
additional role in engendering antimalarial activity.   
 
In addition to the terminal unsaturation, carmabin A possesses an unusual terminal amide. 
Reports of natural products terminating in an amide are uncommon, though those identified are 
typically the result of a ribosomally synthesized peptides that undergo downstream modification 

















































Figure 55.  Cyanobacterial natural products containing an alkyne and amide.
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biosynthesis(83, 84) revealed an NRPS pathway in which the terminal NRPS module is 
dedicated to the activation of an amino acid, peptide bond formation and unusual oxidative 
offloading generating the observed amide.  Motivated by the unique structure of antimalarial 
lipopeptides and we thus sought to elucidate the biosynthetic origins of both the 
pharmacologically significant alkyne as well as the terminal biosynthetically distinct amide.   
 
4.2 Carmabin pathway 
The carmabin sequence was identified redundantly from a screen of a cosmid library prepared 
from genomic Moorea producens 3 (unpublished work) by iterative rounds of primer-walking 
PCR, Sanger sequencing, and shotgun sequencing in parallel though 454 sequencing of multiple 
displacement amplified DNA (85). A draft carmabin cluster was mined from 272 assembled 
contigs and found to span the negative strand of 3 contigs.  The 5’-terminus of the Car sequence 
was defined by the 30987nt contig AEPQ01000195, while the 3’ end was defined by 
AEPQ01000272, which initiates at 18580bp and expands far beyond the 46710 Car terminus.  
The sequences of the two contigs were bridged by AEPQ01000235 the shortest assembled 
construct, 7282 nt, expanding between 10817- 21165.  PCR revealed the complete pathway was 
contained over two cosmids, pCarCOS_L and pCarCOS_R, which were used for all downstream 
molecular biology processes.   
 
The boundaries of the car gene cluster were defined by mining genes 5kbp up- and downstream 
of the last discernable PKS- or NRPS-like protein by screening open reading frames of 100bp for 
proteins putatively involved in secondary metabolism.  A 4.4kbp region is 5’ of the first module, 
which has three open reading frames (ORF) transcribed in the reverse direction ORF1 and 
ORF3, and one in the forward direction ORF2.  ORF1 has high sequence homology with inositol 
monophosphatase from a related species of cyanobacterium Microcoleus sp. PCC 7113, ORFs 2 
and 3 have unknown function but both share high amino acid identity with putative 
cyanobacterial proteins form Microcoleus sp. PCC 7113 and Fischerella muscicola, respectively.  
Directly upstream of the first module, is a 1.2kbp noncoding region that defines the 5’-cutoff.  
The total GC content of the Car cluster was calculated to be 41.2%, which is similar to the 
curacin 42.9%, (12), jamaicamide 42.1% (27), and barbamide, 45.4% (24) natural product 
pathways from Moorea producens. 
 78 
 
The car cluster consists of 10 modules, denoted carA-J, in 10 discrete ORFs expanding 
42069bp, transcribed in a uniform forward direction (Figure 56, Table 5).  At the absolute 5’-
end, three discrete ORFs carA, B, C, encode monodomain proteins that show high homology 
with the terminal Jam proteins.  CarA, 96% sequence identity with jamA, encodes an acyl-CoA 
ligase, falling into the class I-adenylate forming domain superfamily, which generates AMP-
activated species from free fatty acids.  CarB, encodes a protein with putative desaturase 
activity, belonging to the Δ9-fatty acid desaturase superfamily of proteins and sharing incredibly 
high sequence identity, 95%, with jamB.  The predicted protein product of carC is the relatively 
small, stand-alone acyl carrier protein.  Both carC and jamC are 100 amino acids, share the 
invariant active site serine and differ at only 5 residues.  Collectively, these early proteins 
constitute a common starting-tridomain system, predicted in many cyanobacterial alkyne 
containing natural product pathways (86).  
 
A small intergenic break of 143bp precedes the continuation of the car cluster with two highly 
homologous PKS modules, CarD and CarE of approximately the same length, 2553 and 2576 
amino acids respectively.  In addition to the core ketosynthase (KS), acyltranferase (AT) and 
acyl carrier protein (ACP) domains common, both CarD and CarE include the full suite of 
reducing enzymes, ketoreductase (KR), dehydratase (DH) enoylreductase (ER) as well as a C-
methyltransferase (CMT).  Both PKS proteins share very homology 69% and 70%, as well as 
domain architecture with JamJ.  Major differences in sequence identity between the two Car 
proteins are relegated to the docking interfaces at the N- and C-termini.  CarF, G, H and I are 
NRPS monomodules that range in size from 3408- 6912bp depending on domain inclusion.   The 
minimal module CarG, consists of condensation (C), adenylation (A), and peptidyl carrier 
protein (PCP), while CarF and CarH expand domain composition to include a SAM-dependent 
N-methyltransferases.  The largest NRPS module, carI, is the most genetically complex.  As with 
the other modules, the core is comprised of a C, A, and PCP domain, CarI is unique in that 
includes two methyl transferases, catalyzing both N- and O-methylation.  The most intriguing 
element of CarI, is the domain C-terminal of the PCP.  The ~420 amino acid region has high 
sequence homology with proteins from a variety of cyanobacteria including Cyanothece and 
Oscillatoria, however, there is no apparent conserved function for this domain.  BLAST analysis 
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of the enzyme indicated the protein to have reductase, dehydrogenase, or aminotransferase 











































































































































































Amino acids activated by A-domains within each NRPS module were determined by comparison 
of the protein sequence with domain specificities code (87).  CarF likely incorporates a 
phenylalanine, CarG and CarH are both predicted to add alanine, while CarI has the highest 
agreement with tyrosine.   
 
 
4.3 Proposed carmabin A biosynthesis 
The high degree of colinearity between the core structure of the mature metabolite and 
biosynthetic operon led to a proposal for carmabin construction, excluding termination (Figure 
56).  Biosynthesis of carmabin is likely initiated by oxidation of hexanoic acid to 5-hexynoic 
acid, catalyzed by CarB.  The alkynic acid is then activated by the acyl-CoA ligase, CarA, as the 
acyl-AMP and subsequently loaded on the downstream ACP, CarC.  Two rounds of canonical 
PKS elongation and C-methylation are carried out by monomodules CarD and CarE yielding the 
2,4-dimethyldec-9-ynoyl-ACP.  CarF marks the transition between PKS and NRPS biosynthesis, 
which serves to accept the acyl-substrate from the upstream module and catalyzes the additions 
of phenylalanine as well as methylation of backbone amide.  Alanine is added sequentially by 
Table 5.  Deduced functions of the Open Reading Frames in the car gene cluster.  Domain predictions characterized by protein 
BLAST assignment.
Table 6.  Carmabin adenylation domain specificities profiles.  NRPS sequences were compared with amino acid 
recognition as determined by Stachelhaus.  Numbers as denoted by Stachelhaus.  Colors denote proximity of expected and 
observed amino acids.  Black- identical amino acid at the predicted position, blue-±1 amino acids, red- ±4 amino acids, 
green- >7.
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both modules CarG and CarH, however the N-MT domain of CarH modifies the amino acid by 
methylating the β-nitrogen.  The final module CarI incorporates tyrosine into the molecule and 
catalyzes methylation of amide as well the tyrosine para-hydroxy.  Transamination and release of 
the natural product is unclear, but potentially involves the terminal CarI terminal domain.   
 
4.4 Probing alkyne formation  
 
L. majuscula derived lipopeptides, carmabins A and B as well as jamaicamides A, B and C have 
each been shown to make use of fatty acids with varying levels of unsaturation.  These are likely 
formed by putative fatty acid desaturases (FAD) CarB and JamB present in respective 
biosynthetic gene clusters.  CarB and JamB share very high sequence homology with DesC1 and 
DesC2 from Spirulina platensis, which are responsible for catalyzing double bond formation 
between C9 and C10 of stearic acid-derived, 18-carbon fatty acids, attached at the sn-1 and sn-2 
positions of glycerol (88).  These cyanobacterial desaturases belong to the membrane-bound 
fatty acid desaturase-like superfamily, which possesses characteristic hydrophobic regions that 
are proposed to be involved in membrane anchoring, as well as three conserved histidine-rich 
Figure 57.  Alignment of bacterial and plant fatty acid desaturases.  Blue bars indicate conserved histidine rich regions, 
responsible for iron coordination in the active site.  
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4.4.1 Overexpression of CarB in a eukaryotic host 
Investigation of this noncanonical desaturase initiated with carB DNA amplification from 
CarCos_L. The PCR product was cloned into a pET28 vector by traditional methods.  The 
protein was overexpressed in BL21 (DE3) cells harboring the pRARE plasmid. Comparison of a 
time-course overexpression of the CarB compared with empty pET vector, showed no 
appreciation in abundance of a protein corresponding with the expected CarB molecular weight.  
Overexpression of membrane bound proteins using E. coli as a heterologous host are known to 
be challenging REF; In some cases this has been overcome through a combination of optimized 
fermentation conditions and the use of harsh purification protocols, often relying on chaotropic 
reagents and expensive detergents that do not ensure active enzyme.  
 
 
In previous examinations of cyanobacterial fatty acid desaturases, yeast expression platforms 
have been used to successfully reconstitute enzymes (90).  As such, synthetic carB, optimized 








Figure 58.  Density alignment score of fatty acid desaturases from carmabin and jamaicamide pathways.  Transmembrane 
domains are predicted by DAS scores above 1.8.  A.  CarB; B.  JamB.  
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overexpression in yeast.  Recombinant protein overexpression was confirmed by time course 
expression study and analyzed by Western Blot using empty vector as a negative control.   
 
Large-scale cultures of overexpressed proteins were harvested, and purified fatty acid desaturase 
was localized to the yeast microsome (Figure 59). 
 
 
4.4.2 Fatty acid method development 
CarB is proposed to catalyze the conversion of hexanoic acid to 5-hexynoic acid.  In vitro 
characterization of enzymes oxidizing short and medium chain fatty acids is noticeably absent 
from the literature and required novel methods for reaction analysis.  This is made challenging as 
neither the substrate nor product have a chemical functionality that is typically employed for 
biochemical analysis (i.e. UV or fluorescent chromophore, chemical handle for 
functionalization).  Ideally, such a method would avoid radioactivity (i.e. 14C), be amenable to 
tandem protein reaction analysis (i.e. CarA, B, C) and employ an available technology that 
enables determination of multiple enzymatic parameters.    
 
4.4.2.1 Gas chromatography is a standard method for hydrocarbon analysis 









MW Lys Ins Ins Sol Ult Mic
pYESC:CarB
Lys Ins Ins Sol Ult Mic
pYESC
Lys Ins Ins Sol Ult Mic
Figure 59.  Microsome purification of CarB from yeast.  Short chain fatty acid desaturase pYES:CarB was overexpressed and 
purified by in parallel with empty vector, pYESC.  Asterisk denotes expected molecular weight ~43kDa.  A.  SDS-PAGE 
analysis of protein fractions; B.  Western blot analysis of protein fractions.  MW- molecular weight marker, Lys- lysate, Ins- 
insoluble fraction, Sol soluble fraction, Ult- supernatant fraction from ultracentrifuge, Mic- resuspended microsome.
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Examination of short- and long-chain fatty acyl groups has been well achieved by coupled gas 
chromatography (GC) methods.  Typically a GC is placed in-line to separate analytes, which are 
then introduced to the appropriate detector.  Hydrocarbon analysis often employs flame 
ionization detectors (FID), which pyrolyze samples generating signal proportional to the 
abundance of organic atoms in the analyte.  The relatively low boiling points of the C-6 acids 
make GC-FID an excellent candidate for analysis.  GC chromatography method development 
proceeded with equal concentrations of hexanoic acid and 5-hexynoic acid prepared in ethyl 
acetate and the desired baseline separation of the compounds achieved (Figure 60).   
 
Interestingly, the fatty acids exhibited an elution profile with substantial peak fronting.  This 
phenomenon was shown to be concentration dependent, with a uniform peak elution time. 
 
To validate the method, substrate and product acids were prepared as diluted stocks, and added 
to the buffered reaction mixture lacking proteins.  The samples were treated under standard assay 
conditions, extracted with ethyl acetate and analyzed by GC-FID.  Unexpectedly, both substrate 
and product peaks showed substantially reduced signal following workup.  Hexanoic acid 
showed 30% intensity of the control reaction, while the 5-hexynoic acid was less than 2% as 
intense as the control peak (Figure 61). 
1mM hexanoic acid 1mM 5-hexynoic acid
Figure 60.  Short chain fatty acids separation by GC.  Substrate, hexanoate, and product 5-hexynoate, of CarB reactions were 




Though the reaction was prepared below the solubility limit of the free acids, protein amenable 
cosolvents were added to increase the stability of the samples in solution, however the addition 
of methanol, ethanol or dimethyl sulfoxide appeared to decrease the total signal intensity for both 






EtOAC controlIncubated and Extracted 
Figure 61.  Fatty acids incubated in buffer show reduced signal.  1mM fatty acids were incubated and extracted with 




1mM hexanoic acid, 
EtOAC 
1mM 5-hexynoic acid, 
EtOAC
Figure 62.  Cosolvents do not increase fatty acid detection by GC.  Preparation of fatty acids in protein amenable in methanol, 
green trace, ethanol, blue trace, or dimethylsulfoxide, red trace, extracted and prepared for GC-FID 
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4.4.2.2 Headspace analysis of volatile compounds 
The low solubility, high LogP, and difficulty detecting the substrate and product acids following 
incubation led to the hypothesis that the sample was volatilizing over the course of the reaction.   
GC methods forgoing extraction are typically employed when the analyte can be efficiently 
transferred to the gas phase and partition coefficient is sufficiently low for organic solvents.  In 
order to test this, hexanoic acid and 5-hexynoic acid were prepared as before in gas-tight vials.  
Following incubation, samples were heated to 80° while shaking to transfer the maximal amount 
of sample to the gas phase.  The headspace of the reaction vessel was sampled using a gas tight 
syringe, transferred to the GC-FID again no signal was detected.   
 
4.4.2.3 Evaporative light scattering detection of fatty acids 
The difficulty associated with compound detection by GC-FID, led to a reconsideration of the 
analytical method.  Though, neither the substrate nor product possesses a chromophore for 
spectrophotometric detection, analysis could potentially be achieved through alternative optical 
methods.  Evaporative light scattering detection (ELSD) is commonly employed in the analysis 
of non-UV absorbing lipids including cholesterols, cholesteresters and triacylglycerides.  The 
detector is coupled to an HPLC in order to separate compound and samples are then detected 
through perturbations in optical turbidity of the nebulized HPLC eluent.  To begin, samples 
containing either hexanoic acid or 5-hexynoic acid were prepared under reaction conditions, 
incubated, and injected directly without processing or workup.  Substrate and product peaks were 
easily resolvable, with minor contaminants coming from impure standards also observed (Figure 
63). This preliminary analytical method shows promise for characterization of this unexplored 




4.5 Carmabin A possesses a terminal amide 
Carmabin possesses a distinctive amide terminus that is shared by few other natural products, 
including the Moorea producens derived dragonamides (79, 82), macrocyclic antibiotic 
nosiheptide synthesized by Streptomyces actuosus, (81, 82) and myxathiazol derived from 
myxobacteria Stigmatella aurantiaca (83, 84).  It remains unclear how the amide is formed, 
however isotopic feeding studies in S. actuosus indicated that the Nosiheptide amide is derived 
from serine.  More recently, Weinig and coworkers demonstrated that the Myxathiazol amide 
arises as a result of C-terminal cleavage of a glycine added by an adenylation domain in the 
terminal biosynthetic module, MtaG.  These experiments suggested that the carmabin amide may 
also be formed by an A domain possessing a noncanonical function. 
 
4.5.1 CarI Terminal adenylation domain 
Attempts to understand how the carmabin terminal amide is formed began with an investigation 
of the final synthetic module.  Through bioinformatics studies, the CarI terminal domain was 









Figure 63.  HPLC-coupled evaporative light scattering detection enables separation and visualization of short chain fatty 
acids.  Samples denoted on right 
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reductase, or ornithine amino transferase, deep annotation of this domain, led to the renewed 
assignment as belonging to the LuxE superfamily of proteins.  This class of enzyme, which also 
includes the NRPS adenylation domain, uses ATP to activate substrate acid and transfer to the 
downstream thiolation domain.  A tree of representative dehydrogenase, reductase, ornithine 
aminotransferase and adenylation domains firmly places the final CarI domain within the 
adenylation clade (Figure 64).  Thus, the nomenclature for this atypical domain is annotated as a 
terminal adenylation domain or TAD. 
 
 Figure 64.  Cladogram for putative functions of the terminal domain from CarI.
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To examine the activity of the TAD, the domain was cloned from CarCos_R using domain 
specific primers and subsequently cloned into pET28B.  Transformed E. coli Rosetta (DE3) was 
used for protein overexpression.  The enzyme was purified to homogeneity in a single step and 
stored.  To determine the function of the terminal adenylation domain, the pyrophosphate 
exchange assay was employed.  In this experiment the TAD catalyzes the forward reaction 
yielding an acyl-AMP.  The high concentration of inorganic pyrophosphate drives the reverse 
reaction forming a mixture of radiolabeled and unlabeled ATP.  The abundance of radioactive 
ATP is then correlated with substrate preference (Figure 65).  The results of the pyrophosphate 
exchange assay suggest phenylalanine as the likely candidate for activation and use in 
transamination with a normalized 100±0.8% activity, while the nearest activities are for O-























Figure 65.  Pyrophosphate exchange assay to determine CarI terminal adenylation domain amino acid specificity.  Radioactive 
count were normalized to phenylalanine for comparison.  
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These results confirm the adenylation activity of the TAD.  Based on the adenylation domain 
specificity profile it was expected that the TAD would be selective for an aromatic amino acid, 
which is in agreement with the results of the PPE assay.   
 
4.5.2 CarI adenylation-methyltransferase-methyltransferase tridomain  
The role of the duplicate adenylation domain architecture in CarI in forming the terminal amide 
of carmabin is unclear.  To probe this unique enzyme system, adenylation-methyltransferase-
methyltransferase (AMM) tridomain was cloned using standard molecular biology methods.  The 
plasmid was transformed into BL21(DE3)-pLysS+pRARE, in order to minimize basal levels of 
the target gene.   
 
Initially, overexpression of the protein proved challenging as the construct appeared to be toxic 
to the cells, with a complete loss of cell density within 2 hours following induction.  The plasmid 
was used to transform BL21-AI, which has a single chromosomally integrated T7 RNA 
polymerase under an inducible arabinose promoter, which serves to prevent leaky transcription 
pre-IPTG induction and limit rates of mRNA transcription post-induction.  This strategy proved 
successful to maintain cell viability during protein overexpression, however the majority of the 
target protein was insoluble. 
 
The low proportion of the soluble protein may be the result of the improper folding as a result of 
the embedded methyltransferases within the adenylation domain. To increase the proper folding 
of the tridomain, TAKARA chaperone plasmids were screened for their ability to enhance the 
ratio of soluble protein and quantified by densitometry.  The optimized overexpression was 
observed following the coexpression of DnaK-DnaJ-GrpE, increasing the soluble fraction by 





The addition of the non-denaturing, zwitterionic detergent CHAPSO enabled an increase in the 
total amount of the CarI_AMM protein, however a significant portion of contaminating proteins 









MWSol Ins WashFT Frxns
Control +DnaK-DnaJ-GrpEA. B.
MWSol Ins WashFT Frxns
Figure 66.  Overexpression of CarI AMM is dramatically increased with coexpression of protein chaperone.  Expected MW= 
144kDa.  A.  TB+ara  B. TB+ara+DnaK-DnaJ-GrpE.  MW- molecular weight marker, Sol- soluble fraction, Ins- insoluble 
fraction, FT- IMAC flowthrough, Wash- IMAC wash, FRXNS- IMAC stepwise fractions eluted with increasing concentration 
of imidazole
MW Sol Ins WashFT










Figure 67.  Overexpression of CarI AMM is slightly increased upon inclusion of CHAPSO detergent Expected MW= 144kDa.  
A.  TB;  B.  TB+ CHAPSO.  MW- molecular weight marker, Sol- soluble fraction, Ins- insoluble fraction, FT- IMAC 
flowthrough, Wash- IMAC wash, FRXNS- IMAC stepwise fractions eluted with increasing concentration of imidazole
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This overexpression platform, while successful, was both time and reagent sensitive and a 
simplified method was sought.  The addition of the chemical chaperone, TMAO has been used in 
the past to both solubilize and promote proper folding of proteins in E. coli overexpression 
systems.  At low concentrations TMAO enabled the use of standard overexpression cell lines 
BL21DE3+pRARE, obviating the need for tight AI control (Figure 68).  Increasing the 




Carmabin A is a structurally intriguing cyanobacterial natural product representative of a class of 
antimalarial lipopeptides.  The initiating steps in carmabin biosynthesis leading to alkyne 
formation, putatively involve the activation and oxidation of hexanoic acid to 5-hexyonic acid 
via the acyl-CoA ligase (ACL) CarA, fatty acid desaturase (FAD) CarB and standalone carrier 
protein, CarC, though the mechanism is unclear.  To date, all known cyanobacterial FADs have 
been shown to act on acyl chains that are bound to a head group as in glycerolipids, as activated 
CoAs, or bound to an acyl carrier protein (ACP) (88, 90-92).  In vitro assays of membrane bound 
desaturases have demonstrated a ferredoxin dependence, suggesting a likely in vivo Red/Ox 
MW Sol Ins WashFT










Figure 68.  Overexpression of CarI AMM is slightly increased upon inclusion of chemical chaperone.  Expected MW= 
144kDa.  A.  TB;  B.  TB+ TMAO.  MW- molecular weight marker, Sol- soluble fraction, Ins- insoluble fraction, FT- IMAC 
flowthrough, Wash- IMAC wash, FRXNS- IMAC stepwise fractions eluted with increasing concentration of imidazole
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partner, however detailed investigations into the activity and of FADs involved in natural 
products biosynthesis have yet to be conducted.    
 
In the initial report describing biosynthesis of the alkyne-containing natural product jamaicamide 
A, Edwards et al. (27) successfully overexpressed and purified JamA, an acyl-CoA synthase 
(ACS).  Once loaded, the FAD, JamB, was proposed to desaturate the fatty acid chain to form 
either an alkene or alkyne that are subsequently extended to form jamaicamides A-C.  Contrary 
to the expected saturated hexanoic acid substrate, JamA showed an unexpectedly high preference 
for 5-hexenoic and 5-hexynoic acids via the pyrophosphate exchange assay.  This lends support 
for a counter-canonical activity of JamB and CarB as unique FADs, with a proclivity toward 
utilizing free acids as substrates, suggesting desaturation occurs prior to loading onto the ACP. 
Interestingly, carmabin B possess a terminal methyl ketone, rather than the expected alkyne.  The 
flexibility observed for JamA, to accept a variety of the fatty acid substrates, may be partially 
extended to the, CarA, as a possible explanation for the presence of this functional group.   
 
Based on the structures, will also presumably see FAD domains as part of the biosynthetic 
machinery responsible for the antanapeptins, pitipeptolide, and wewakpeptins (21).   Within 
cyanobacterial natural products the isolation of small molecule analogues with variable fatty acyl 
oxidation (e.g. antanapeptins A-C with alkyne, alkene and alkane functionalization, respectively) 
suggests that the downstream modules are tolerant of deviations from pathway colinearity and 
that early loading domains are substrate flexible, in agreement with the semi-promiscuous 
activity observed for JamA.  
 
The termination events leading to amide formation in carmabin A similarly remain elusive.  
Bioinformatic analysis and biochemical characterization of the CarI terminal domain (TAD) via 
the pyrophosphate exchange assay identified this protein as an adenylating enzyme plausible 
candidate for catalyzing transamination.  Potentially, release involves the addition of second 
phenylalanine, activated by the CarI TAD, of which only the amine remains in the mature 
molecule.  Isotopic feeding studies using 15N-labeled amino acids could be used to decisively 
determine the origins of the nitrogen. 
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While terminal amides in natural products are not common, myxobacterial metabolites have 
demonstrated an unusual abundance, of which the biosynthetic origins have begun to be 
characterized.  Recently, the myxathiazol amide was discovered to be the result of a complete 
NRPS module, MtaG, using an N-acetylcysteamine substrate surrogate (84).  Here, the A- and C- 
domains catalyzed activation and condensation of glycine onto the growing chain, attached to the 
downstream peptidyl carrier protein (PCP).  An embedded flavin monooxygenase catalyzed 
oxidative chain release, resulting in the amide-containing NP and a PCP-bound 2-oxoacetate.  In 
order to regenerate the holo-PCP, the adjacent Type-II thioesterase (TE) hydrolyzed the thioester 
yielding the reduced phosphopantetheine thiol and free glycolic acid.  This type of housekeeping 
ensures the viability of the terminal module for multiple rounds of biosynthetic catalysis. 
Interestingly, characterization of the closely related ester-homologue, melithiazol led to the 
identification of two additional proteins in that cluster, MelJ and MelK, that catalyzed 
amidohydrolase and methyl transferase activities, respectively (83).  This finding indicates that 
amide offloading of natural products may be more a more common strategy during biosynthesis 
than previously understood, based exclusively on the structure of the isolated compounds. 
 
Deep annotation of the carmabin gene cluster resulted in the identification of a previously 
unrecognized Type-II TE.  The presence of this terminal protein in the carmabin pathway 
supports the hypothesis that the carmabin A amide is amino acid derived in a fashion potentially 
similar to Myxothiazol.  The standalone TE may also play a role as a holding domain, similar to 
what has been observed in iterative NRPS gramicidin S pathway (93).  Hoyer et al. demonstrated 
that during biosynthesis, one half of the dimeric pentapeptide Phe-Pro-Val-Orn-Leu, was fully 
elongated, and transferred to the GrsB-TE.  The second pentapeptide was again generated by the 
NRPS and attached to the terminal PCP.  Remarkably the TE catalyzed both dimerization of the 
peptides, as well as subsequent cyclization. 
 
Unlike myxathiazol biosynthesis, the absence of a dedicated transamidating module in the 
carmabin cluster compels a further investigation into the potential function of the terminal CarI 
domain.  Recently, bifunctional adenylation domains have been identified in a number of natural 
product pathways capable of catalyzing not only amino acid activation but also peptide 
condensation.  In the biosynthesis of the aminoglycoside streptothricin, a standalone domain, Orf 
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19, was demonstrated to possess both the A- and C-domain like activities.  This 59 kDa protein, 
activated β-lysine as the amino acyl-AMP, as well as catalyzed subsequent head-to-tail 
condensation with a carrier protein bound β-lysine, loaded by a separate standalone adenylation 
domain, Orf 5.   Remarkably, Orf 19 was able to catalyze seven iterative rounds of tandem 
activation and condensation, in agreement with the longest β-lysine chain length found on 
streptothricin X.  
 
Similary, biosynthesis of the aminocoumarin antibitoics novobiocin and coumermycin A1, 
involve a bifunctional amide synthethase(94, 95).  NovL and CouL were both shown to catalyze 
an initial adenylation step with 3-dimethylallyl-4-hydroxybenzoic acid and 3-methyl-1-pyrrole-
2,4-dicarboxylic acid, as substrates respectively.  Following activation, the acyl-AMPs were 
condensed with the core 3-amino-8-methyl-4,7-dihydroxycumarin ring.  Interestingly, CouL was 
also responsible for a second round of activation and condensation with the carboxylic acid at the 
C4 position and an additional dihydroxycoumarin ring. 
 
With the groundwork in place, investigating alkyne formation and amide production in carmabin 
A are rapidly taking shape.  Understanding the precise mechanism of the unusual initiation and 
termination events will guide future examination of marine cyanobacterial biosynthesis. 
 
4.7 Materials and methods 
Bacterial strains, media and culture conditions. 
Escherichia coli DH5α subcloning efficiency cells (Invitrogen) were used as axenic stocks for 
the preparation of electrocompetent cells for DNA propagation and maintenance.  Escherichia 
coli BL21-pLysS and BL21-AI (Novagen) harboring the pRARE plasmid (spectinomycin 
resistance exchanged for chloramphenicol by Dr. W. Clay Brown, University of Michigan) were 
used for general protein overexpression.  All transformations were achieved via electroporation 
(BioRad, Gene Pulser Xcell), with 2.5-500 ng DNA from ligation reaction mixture or as intact 
plasmid, recovered with SOB, allowed to outgrow for 60 minutes prior to plating on lysogeny 
broth-Miller-agar plates (LB-Miller) supplemented with the appropriate antibiotic (ampicillin- 50 
µg/mL, kanamycin- 50 µg/mL). 
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Protein overexpression using E. coli as a host organism 
Fresh transformants harboring the plasmid of interest were used to inoculate a culture of 
lysogeny broth-Miller (LB-Miller).  Overnight (~12-18 hours) cultures were used to subinoculate 
(1:100 (v/v)) large-scale (500-1000 mL) cultures of LB-Miller for the TAD and either 2XYT or 
Terrific Broth (TB) for the A-MT-MT tridomain, supplemented with appropriate antibiotics for 
protein overexpression.   
 
For the TAD and large-scales cultures were grown at 37° while shaking at 160 RPM until 
reaching an OD600 0.8-1.0.   Flasks were allowed to cool at room temperature for 60 minutes.  
Protein overexpression was induced with the addition of isopropyl-β-D-thiogalactopyranoside 
(IPTG) to a final concentration of 0.2 mM.  Flasks were returned to an 18°C shaker and 
continued to grow for an additional 12-14 hours.  A-MT-MT tridomain were treated similarly 
with the addition of 50 mM TMAO to the culture media.  A-MT-MT producing cells grown in 
BL21-AI were grown at 37°C until an OD of 0.4, at which point arabinose was added to a final 
concentration of 0.2 mg/mL.  The culture cooled passively in the shaker at a temperature of 24°C 
until an OD of 1.0 was reached.  Overexpression was initiated following the addition of 0.1mM 
IPTG to the culture, which was allowed to grow at 15°C for an additional 10-16 hours.  Cells 
were harvested by centrifugation at (5000xg, 10 minutes, 4°), transferred to 50 mL Falcon tubes 
and cell pellets were flash frozen in liquid nitrogen and stored at -80° until purification. 
 
Protein purification from an E. coli heterologous host 
All steps during the protein purifications were performed at 4°.  Cell pellets were resuspended in 
2x cell volume (minimum 25mL) 5% Buffer B, and incubated with freshly prepared lysozyme 
(0.2 mg/mL final, prepared in MilliQ H2O), freshly prepared PMSF (2 mM final, prepared in 
DMSO) and 1 cOmplete protease inhibitor cocktail (Roche) tablet for 60 minutes while rocking.  
Cells were lysed by use of a recently tuned ultrasonic dismembrator for 10 cycles of 1 minute, 
with pulses of 5 seconds on, followed by 5 seconds off, and intensities ranging from 7-8.  All 
cycles were carried with chilled beakers in packed ice bucket.  Cellular debris was removed by 
centrifugation at 40000-50000xg for 30 minutes and the supernatant was transferred to a fresh 
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tube; residual insoluble material was removed by filtration (syringe driven 0.45 µm filter) or a 
second round of centrifugation.   
 
Immobilized metal affinity chromatography  
Clarified lysate was applied to a 5 mL HiTrap IMAC column (GE) charged with Ni2+, and 
equilibrated with 5% Buffer B prepared with or without CHAPSO mounted on an AKTA FPLC 
(GE).  The resin was washed extensively with 25 column volumes of 10% buffer B to remove 
any nonspecifically bound proteins.  The target protein was eluted with a linear gradient from 15-
100% Buffer B.  Peak fractions as determined by gradient SDS-PAGE ((4-12%) (Novex 
NuPage) run in MOPS buffer at 200 mV for 30 minutes) were pooled and concentrated using 
Amicon ultra centrifugal concentrators (Millipore, 10 kDa, 50 kDa), equilibrated with Buffer F 
until a volume of 2.5 mL was reached.  Proteins were buffer exchanged with a PD10 washed and 
equilibrated with Buffer F and eluted with 3.5 mL of Buffer F.  Proteins were further 
concentrated to less than 100-500 µL, aliquoted, flash frozen in liquid nitrogen and stored at -
80°.  Protein concentrations were determined using the bicinchoninic acid assay (BCA Pierce) 
according to the manufacturers guidelines, using a BSA standard curve and read in 96 well 
format. 
 
Yeast protein overexpression of the fatty acid desaturase 
Synthetically prepared CarB (GeneArt) was subcloned from pMA vector into the pYESC yeast 
expression vector (Life Technologies) according standard molecular biology practices.  The 
uracil auxotrophic INVSC-1 yeast strain was transformed with the pYES-CarB according to the 
manufacturer’s guidelines.  Protein overexpression and yeast microsome preparation were 
carried out in concordance with protocols outlined by the manufacturer with no modification.  
Detection of the overexpressed yeast protein was carried out by Western blot and using the Anti-
HisG-HRP antibody (Life Technologies) and visualized using the ECL Prime Western body kit 
(GE Healthcare). 
 
Short chain fatty acid analysis by GC-FID and RP-HPLC-ELSD 
Method development for GC-FID analysis of fatty acids was guided by the work described in 
Das et al. (96).  Modifications to the temperature gradient for extracted samples were optimized 
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to ensure baseline separation of the C-6 acids.  Preparation of the reaction mixture for fatty acid 
detection by ELSD was the same as above, excluding the extraction with ethyl acetate. Samples 
were injected directly onto an ACE AQ column (ACE 3 µm, 100 mmx 3.0 mm) equilibrated in 
10% CH3CN mounted on a Beckman Coulter HPLC. A gradient of 10-95% CH3CN over 20 
minutes, followed by a 5 minute wash at 95% CH3CN and reequilibration at 10% 
CH3CN+0.1%FA for 10 minutes.  Column elution was directed to an ELSD (Alltech) with N2 
nebulizing gas running at 1 l/min.   
 
Pyrophosphate exchange characterization of the TAD 
Activity assay characterizing the domain activity the terminal adenylating enzyme was carried 
out using a protocol adapted from.(97, 98).  Briefly in a 100 µL reaction  (50 mM Tris (pH= 7.2) 
100 mM NaCl, 1 mM MgCl2, 10% (v/v) glycerol, 10 mM ATP, 1 mM DTT 32P labeled  
pyrophosphate (100 µM, 2 µCi/µMol) 500 µM cold pyrophosphate) 5 mM amino acid was 
incubated with 10 µM TAD for 60 minutes at 24°C.  The reactions were quenched with the 
addition of 10% (v/v) ice-cold trichloroacetic acid (TCA) and followed by 500 µL of a Norit 
suspension (2.0% (w/v) activated charcoal.  The activated charcoal was pelleted by and 
washed thrice with 1 mL of 100 µM pyrophosphate and 10% TCA in MilliQ H2O.  The 
charcoal was resuspended in 500 µL MilliQ  H2O and 3.5 mL scintillation solution and 
percent bound determined by scintillation counting.   
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5.1 Megasynthase enzymology  
Exploring polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) global 
enzyme strategy is a rapidly expanding field of study, relying increasingly on advanced 
techniques and methodologies to parse the complex and multistep biosynthetic process (10, 11).  
Evolutionarily, PKSs are presumed to derive from enzymes involved in fatty acid metabolism 
(99).  Bacterial Type II fatty acid synthases (FAS-II) are composed of discrete domains which 
complex to catalyze formation of fully saturated acyl chains.  FAS domain shuffling and 
exclusion likely led to ancestral PKS pathways with architecture similar to the trans-acting 
Type-II PKS systems, while the megaenzymes that we observe for Type-I PKSs resulted from 
gene fusion of co-regulated clusters.    
 
While the overall biosynthetic product is similar between FAS and PKS systems, the mechanism 
by which the substrate, bound to the acyl carrier protein (ACP) within a given module or as part 
of the trans-protein-complex, discriminately interacts with individual catalytic domain remains 
elusive.  The unusual mixed cis- and trans- acting β-branching systems(37), as exemplified by 
CurA-CurF, further complicate this process requirements by requiring a tandem carrier proteins 
array to engage with domains nonsequentially during single catalytic cycle (i.e. substrate bound 
to the CurA ACPI+II+III+Cd must first undergo extension carried out by CurA PKS domains, 3-
hydroxy-3-methylglutaryl formation is catalyzed by the standalone HMG-CoA synthase, 
reengagement with the intramodular Halogenase for chlorination to occur, followed by 
dehydration by the standalone enoyl-CoA hydratase, decarboxylation by a second enoyl-CoA 
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hydratase as part of the downstream module and subsequent cyclization yielding the 2-methyl-
cyclopropyl moiety) (40).  Moreover the role of the C-terminal flanking domain (Cd) in 
mediating specific contacts as a means of facilitating enhanced biosynthetic flux through that 
system is incredibly unique(38).  
 
5.1.1 Type-I PKS modular strategy  
Inroads into understanding the forces that govern such protein-protein interactions are beginning 
to be made.  Notably, the recent kinetic characterization of modular loading evens by Bonnet and 
Rath (100) provide evidence for an effect of the substrate and ACP isoform on the rate of 
catalysis by the acyl transferase (AT). By monitoring free CoA production, under steady-state 
conditions, wild type PikAIV was demonstrated to catalyze processing of the native substrate, 
methylmalonyl-CoA, 1.4-fold faster in the presence of a phosphopantetheinylated, holo-ACP, 
rather than non-posttranslationally modified, apo-ACP, demonstrating the significance in 
competent interaction between domains in the priming event during in the first step in PKS 
function.  Interestingly, for the non-native substrate malonyl-CoA, the AT appeared 5.17-9.36-
fold more active for the holo- and apo- ACPs, respectively. This apparent increase in rate can be 
understood to be the result of the evolved discrimination of the AT and ACP domains for the 
correct extender unit, indicating the marked role that the substrate and plays in driving PKS flux.     
 
These conclusions are further supported by the characterization of the PikAIII module by 
Whicher and Dutta (unpublished data), wherein cryo-electron microscopy revealed structural 
rearrangements and remarkably precise localization of the ACP over the course of a single round 
of modular catalysis in a principally substrate driven mode.  In the presence of keto synthase 
(KS) loaded pentaketide, but absence of the extender unit, holo-ACP resided exclusively at the 
AT, pausing until loading can take place.  Withholding chain elongation intermediate, but 
providing the extender unit methylmalonyl-CoA led to the ACP occupying space below the 
internal KS active site tunnel.  Addition of both the pentaketide and methylmalonyl-CoA, 
yielded the extended β-keto-hexaketide and a complete repositioning of the ACP to the 
ketoreductase (KR) domain.  Supplementation of the reaction with NADPH, led to β-alcohol 
formation and unexpectedly the ACP appeared to eject from within the PKS dimer active site 
arch, in position to engage with the KS of the downstream PikAIV module and via the well 
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established donor-acceptor docking interactions.  The unexpected spatial localization of the ACP 
in response to the loaded substrate clearly demonstrates a process by which the noncatalytic ACP 
is involved in recognition and transposition of the nascent intermediate in order to engage with 
individual catalytic domains at explicit moments during catalysis.   
 
5.1.2 Iterative Type-I PKS enzymology 
These studies demonstrate that within a module, during a single PKS cycle, the sequence of 
protein-protein interactions is substrate determined.  An expansion of these works characterizing 
the interdomain recognition of substrate within Type-I systems can be expanded to probe the 
intramodular interactions involved in iterative PKS (IPKS) metabolism.  Typically observed in 
fungi, a single module consists of the core PKS domains as well as the full complement reducing 
enzymes (KR, dehydratase, (DH) and enoyl reductase (ER)), and is wholly responsible for small 
molecule scaffold assembly (101).  In the biosynthesis of the fungal metabolite lovastatin, LovB, 
an eight-domain module (KS-AT-DH-MT-ER0-KR-ACP-C) and stand alone ER, LovC, catalyze 
the condensation and nine malonyl-CoAs generating the natural product core dihydromonacolin 
L (102).  Totally unknown are the forces that constrain individual proteins to be either excluded 
or included during modular turnover, however recent evidence suggests that this may also be 
substrate guided; this is especially apparent for the α-methylation event during the fourth round 
of LovB catalysis.  In the absence of productive methyl transferase interaction, experimentally 
by withholding S-adenosyl-methionine from the reaction mixture, Ma et al. demonstrated that 
the IPKS module is still able to process substrate, however biosynthesis leads to undesired 
pyrone formation and premature offloading.   
 
In cytochalasan biosynthesis, the IPKS modules are further expanded to incorporate the three 
core NRPS domains (condensation (C), adenylation (A), peptidyl carrier protein (PCP)) and 
reductase (Red), C-terminal of the ACP.  Counterintuitively, the natural products generated by 
these pathways have only a single amino acid as part of the final structure.  The shape adopted 
by this hybrid IPKS-NRPS in protein-space and mode by which the iterative PKS activity 
remains disconnected from NRPS function is totally unknown.  The strategy used by these more 
exotic PKS systems to delineate intermediate processing and domain incorporation in generating 
the desired product is clearly in response to ACP-bound substrate.   
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5.1.3 Acyl carrier proteins as active participants during small molecule assembly 
Understanding the forces that govern PKS turnover will provide insight into the discrimination 
of CurM and Synechococcus olefin synthase to offload the metabolite as the alkene, as well as 
the mode by which β-branching proteins interact.  The role of the carrier protein in guiding 
interaction has begun to be investigated in a number of Type-I systems, however with little 
consensus.  Evans and coworkers (103) have observed conformational dynamics that take place 
during the actinorhodin ACP transition from apo- to holo-, with a corresponding decrease in 
affinity for the phosphopantetheinyl (PPant) transferase, FAS-holo-synthase (ACPS).  
Conversely, Busche et al. (53) only identified minor structural changes of the CurA ACP triplet 
upon addition of the PPant.  In studying fatty acid metabolism, Ploskon et al. (104) observed 
significant interactions of the proximal portion of the acyl substrate and a hydrophobic binding 
cleft generated by αHIII and αHIV of the Streptomyces coelicolor FAS ACP, however no such 
sequestering was observed for the homologous human FAS proteins (105).   A comprehensive 
appreciation of the substrate-ACP and ACP-catalytic domain associations are critical for 
reaching the long-term goal of secondary metabolite pathway engineering.  Similar to PKS 
systems, protein-bound substrates within NRPSs must engage with catalytic domains in a precise 
manner, though a less thorough treatment exists in the literature (106).  By minimizing the 
judicious interactions, which limit productive modular function, nonnative substrates can be 
successfully incorporated into the final compound. Advanced characterization of the specific 
interdomain contacts within PKS, IPKS, NRPS, mixed systems and pathways including β-
branching cassettes will certainly be a component of the next stage in megasynthase 
enzymology. 
 
5.2 Chain elongation intermediates as pseudo-activity based protein-profiling probes 
A major gap in the natural product sciences, is the disconnect between the isolation of small 
molecules and identification of the responsible biosynthetic gene cluster.  As next generation 
sequencing technologies become accessible and bioinformatic tools become progressively 
refined, the frequency and ease with which whole genomes are screened for biosynthetic 
pathways is rapidly increasing (11).  Practically, this can still be challenging, as there are often 
silent or cryptic gene clusters with no corresponding small molecule, as well as secondary 
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metabolites that may deviate from the product as predicted by the biosynthetic protein template, 
both of which obfuscate analysis.  Experimentally Rath et al. (16) partially addressed this 
limitation by simultaneously characterizing the metagenome, metaproteome and 
metametabolome of a marine invertebrate and associated microbiome known to produce the 
chemotherapeutic ET-743.  While both time and resource intensive, this method demonstrated 
the utility of a cotemporaneous examination of a single system using multiple biological metrics 
as a means validating the assignment of a small molecule to biosynthetic machine; however, this 
technique was unable to ascribe complete domain function for key metabolic steps. 
 
The terminal unsaturation present on carmabin A, has incredible implications for use in 
deciphering natural product biosynthesis.  As a chemical handle, alkynes have been widely 
exploited for a rapid and specific functionalization via bioorthogonal chemistry (107, 108). 
Acting as a pseudo-activity based protein profiling (pABPP) probe (109-114), alkyne-containing 
pathway intermediates, could be derivatized using “Clickable” techniques.  One such scenario 
envisions the addition of azide-linked biotin to lysed cyanobacterial culture during peak 
carmabin production, which undergo the expected [3+2] cycloaddition.  As the nascent chain 
remains chemically tethered to the module during catalysis via the carrier protein thioester bond, 
all biosynthetic proteins could be enriched for via streptavidin pulldown.  Peptide mapping by 
bottom-up mass spectrometry (MS) could then be used to determine the protein identity and the 
associated biosynthetic intermediate could simultaneously be determined by tandem MS.  This 
single-step enrichment of both the metabolite and corresponding enzymatic machinery from 
crude cell mass vastly simplifies the pathway identification workflow and would provide direct 
evidence for the order of catalytic steps.   
 
Elements of this proposal have already been shown successful in the literature.  In a proof of 
principle study examining NPRS interaction Hur et al. (115) demonstrated that chemical 
crosslinking can take place between cognate modules upon loading PCP domains with either an 
alkyne or azide appended to a PPant derivative.  Meier et al. (116) have taken advantage of the 
presence of the ubiquitous phosphopantetheine group from enriched biological material as a 
diagnostic mass spectrometry tool in order to confirm and sequence-identify the presence of a 
whole modules from crude sample.  Similarly, Yap and Kostiuk et al. (117) have shown that 
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proteins post-translationally modified with and alkynyl fatty acids successfully undergo triazole 
formation with a biotin-linked azide, under in vivo and in vitro conditions.  Moreover the protein 
conjugates could be easily enriched from HeLa cells and identified by streptavidin pulldown and 
bottom-up MS.   
 
Through this combinatorial chemical-biology approach and utilizing recent advances in mass 
spectral networking(118, 119), families of natural products, along with the corresponding 
intermediates can be rapidly identified.  Furthermore, the enzymatic machinery responsible for 
the biosynthesis of such small molecules could also be identified in a single step.  The 
experimental workflow attempts to broaden the use of natural product intermediates as pABPPs, 
however this is met by the obvious limitation of the finite number of small molecules with a 
terminal unsaturation.  Common bioconjugate reagents such as isocyanates, which are both 
hydroxyl and amine reactive, would be unable to distinguish between small molecule and 
biomolecule and would be an unreasonable alternative.  An option to include an initial protein 
chromatographic step would help bias toward the larger megasynthases and could be followed by 
parallel examination by multiple reactive probes could.  Ultimately the technique outlined above 
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